Podcasts about ATR

Hoy celebramos el Día Mundial de la Radio, el medio más bonito y mágico que existe, con una sesión a base de canciones que nos habéis recomendado y que son perfectas para esta jornada. MORGAN - RadioMICHAEL KIWANUKA - BLACK MAN IN A WHITE WORLDARCTIC MONKEYS - R U Mine?THE MOLOTOVS - Today's Gonna Be Our DayOASIS - WonderwallRAMONES - Do You Remember Rock'n'Roll Radio?WET LEG - Mangetout (The Dare remix)FCUKERS - I Like It Like ThatFONTAINES DC - StarbursterIDLES - I'm ScumEXTREMODURO - La Vereda de la Puerta de AtrásROBE - El Hombre PájaroVEINTIUNO - Estarás BOTÁNICO DÉCIMO ANIVERSARIOFred again.. - ⁠Beto’s Horns (Ezra Collective remix)FKA Twigs ft NORTH WEST - Childlike ThingsEscuchar audio

El Festival Internacional Escolar y Universitario de las Artes Audiovisuales (eMove International Festival) ha publicado el libro conmemorativo de su décimo aniversario, "Crea, Sueña, Atrévete", con el que celebra una década de las artes audiovisuales y la educación.En él han participado con artículos 21 instituciones del panorama audiovisual español, entre ellas la Academia de Cine, el Icaa,Rtve, las universidades de Valencia y la Asociación de Informadores cinematográficos de España, entre otras. El festival ha abieryo ya su nueva convocatoria hasta el 30 de junio.Escuchar audio

En este episodio del videopodcast Atrévete a Ser de Elisa Queijeiro, conversamos con Leila Canavati, quien durante años fue una empresaria exitosa hasta que un día decidió escuchar su intuición, honrar sus sueños y dar un giro radical a su vida para dedicarse a la astrología.Leila dejó el mundo corporativo para seguir una vocación profunda: leer el cielo como una forma de entender la vida. En esta conversación hablamos de por qué tantas mujeres estamos volteando a ver la astrología, qué significa buscar sentido en un mundo que a veces se siente incierto y por qué el deseo de comprendernos a través de las estrellas va mucho más allá de una moda pasajera.Juntas reflexionamos sobre intuición, crisis, propósito y el valor de tomar decisiones que nos acerquen a quienes realmente somos. Yo te invito a escuchar este episodio como una pausa para preguntarte si la astrología tiene un mensaje para ti y, sobre todo, para cuestionarte qué sueños estás lista o listo para honrar.Este episodio llega a ti gracias a Actinver, acompañándote a construir las mejores historias de tu vida.¡Hola, soy Elisa Queijeiro!Nací para contar historias. Soy humanista, escritora y académica, pero sobre todo, soy una mujer hambrienta de aprender. Descubrí que las verdades del pasado pueden inspirarnos hoy si las sabemos escuchar.

Success is simply a matter of luck. Ask any failure. — Earl Wilson Prior Session's Trade Execution Summary Grid: Receive TODAY's Trade Execution Summary Grid, our Complete Analysis & Predictions of Stocks, Bonds, Gold & Bitcoin by becoming a Patreon Member at any of our three levels of support: https://bit.ly/CWPatreonSupport Sign up at Trading View access my platform and charts: https://www.tradingview.com/?aff_id=136493 How to Set Up Our Three Time Frame Chart on TradingView: https://youtu.be/wLwTnrtAOTA I have opened my page to sharing. Find me on TradingView at Thom Goolsby. Here at Charting Wealth, we focus on the reality of price movement by following trends. We teach you a simple and effective method to read stock, ETF and crypto charts, keep your emotions in check and learn when to buy and when to sell. Charting is your road map to the market and the riches it can offer. Forget the hype you see and hear in the financial news media. They are selling products in print ads and commercials. Focus on what is real, no matter how hard it can be to believe! Otherwise, you become a sucker or worse, a slave, to the delusion someone else wants you to believe. Use the lessons we teach every day to accurately chart any stock, commodity, ETF and cryptocurrencies. We give you daily, real life lessons with the five ETFs we track: S&P 500, NASDAQ 100, 20-Year Treasury Bonds, Gold and Bitcoin. We have all the tools you need to learn how to trade. For subscribers, we have a GREAT TRAINING to SUPERCHARGE your practice trading: "Maximize Success with ATR." If you are not a subscriber, become one! Subscribe for FREE to our daily market reviews & training at http://www.ChartingWealth.com We urge you to "Follow the charts, NOT the noise!" and want to help you follow the market and improve your knowledge of stock and ETF movements. Support our work at PATREON and receive GREAT benefits (training, gifts, etc...): https://www.patreon.com/user?u=14138154 Receive our STOCK ALERTS via TEXT when WEEKLY VERTICAL CROSSOVERS occur. Very valuable information! Less than 8 texts a month. Text "chartingwealth" to 33222 on your cell phone. At ChartingWealth.com, http://chartingwealth.com every day the market is open, we chart the S&P 500, NASDAQ 100, Gold & Bonds. In just a few short minutes, we give you a valuable training update and quickly review the trends we see taking place in the market. At the end of every week, we give you an overview of what happened over the last five days and what's on the calendar for the next trading week. DISCLAIMER: We offer NO advice and make NO claims to expertise of any kind. This site is dedicated to knowledge and education through our stock chart training, reviews and other information -- nothing more.

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.Silver just dropped hard… and the fake gurus are already lining up with their “I told you so” takes. Sound familiar? In this live trading session, the focus is not on predicting headlines or chasing hype. It is on managing risk, rolling options intelligently, and executing a proven trading plan inside the U.S. Investing Championship.Instead of obsessing over why silver crashed 24 percent, this breakdown goes straight to what actually matters: portfolio impact. You will see, step by step, how aggressive pullbacks in stocks like KGC, NEM, OR, and others would have resulted in brutal losses if positions were left untouched. But by systematically rolling options for credit, risk was reduced dramatically and trades that should have been down big were flipped into controlled outcomes and even gains.This is not theory. This is live execution inside the OVTLYR Trading Room.Here is what gets covered:✅ How rolling turned a 35 percent losing option into an 18 percent gain✅ Why letting contracts drift inside seven days to expiration destroys expectancy✅ How to reduce 70 to 80 percent of risk while giving up only a small portion of upside✅ The math behind return to risk and why professionals focus on process over prediction✅ Why a stock can be flat or down and your options position can still be greenOne of the most powerful takeaways is this: every original option contract, if left unrolled, would have been negative. Every single one. The average return without rolling was roughly negative 22 percent. With rolling? Positive double digits and drastically lower capital at risk.That is not luck. That is risk-first trading.You will also see the discipline behind closing positions when rules demand it. No emotional attachment. No revenge trading. No “just one more day.” If a contract cannot be rolled for credit inside the rules, it gets closed. Period. That is how consistency is built.The session also walks through the broader market context using SPY signals, fear and greed heatmaps, 10/20 EMA structure, ATR stop levels, and value zone entries. Instead of forecasting, the focus is on reacting to confirmed signals. That is how sustainable edge is developed over time.This is exactly how capital is protected during volatility while still staying positioned for opportunity.If you want to understand:• Advanced options rolling strategy• Risk management for swing traders• How to trade pullbacks without panic• How to compete in a live investing championship• How to follow a rules-based system without emotional noiseThen this video is for you.The entire approach centers around one core principle: professionals manage risk first. If the process is sound, the money follows.If you are serious about leveling up your trading, subscribe, follow the live sessions, and dive into the OVTLYR platform to see how the signals, breadth data, and portfolio tools work together in real time.This is how traders move from guessing… to executing with confidence.

¡Atrévete a ser abundante y no lo dudes! El Dr. César Lozano trae para ti para mantener la abundanci y la felicidad en tu vida. Es tiempo de agradecer y disfrutar el Año Nuevo 2026 escuchando Por el Placer de Vivir con el Dr. César Lozano. Disponible en Uforia App, Apple Podcasts, Spotify, ViX y el canal de YouTube de Uforia Podcasts.¿Cómo te sentiste al escuchar este Episodio? Déjanos tus comentarios, suscríbete y cuéntanos cuáles otros temas te gustaría escuchar en #porelplacerdevivir 

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.If you've ever wondered how a professional investor actually screens for stocks instead of guessing, chasing headlines, or gambling on earnings, this breakdown walks you through the full process step by step. This is the exact framework used while competing in the U.S. Investing Championship, and it is built around structure, data, and risk control. Not hype. Not hope. Not predictions.The process starts with the market itself. Before even looking at individual stocks, the first question is simple: is the S&P 500 in a bullish trend? Is there a confirmed buy signal? What is the Fear and Greed heatmap doing? If the market environment does not align with the rules, no new trades. Period.Then comes breadth. How many stocks are actually trending up versus down? Are buy signals accelerating or evaporating? This is not about guessing direction. It is about measuring participation. When defensive sectors like utilities and staples begin outperforming, that tells a very different story than when aggressive sectors are leading. That context matters.From there, the focus narrows into sectors and finally into individual stocks using a structured screener. The goal is not random stock picking. The goal is stacking probabilities.Here is a simplified version of what is being evaluated:✅ Market trend and buy signals✅ Sector relative strength versus SPY✅ Breadth confirmation and acceleration✅ Fear and Greed heatmap direction✅ Volume, price filters, and current signal statusOnce a stock passes through those filters, the next layer is performance analysis. Not just raw returns, but capital efficiency. A stock might show similar total returns compared to buy and hold, but if it only requires capital 31 percent of the time, that changes everything. That means capital can be deployed elsewhere instead of sitting idle. That is how you increase expectancy without increasing risk.Risk management is the foundation throughout this entire strategy. Rolling options to reduce exposure. Avoiding stale signals. Ignoring profit targets that anchor psychology. Reducing risk as trades move in your favor instead of pyramiding recklessly. Even earnings are treated as calculated risk events, not emotional bets.Order blocks, gap and go versus gap and crap setups, ATR levels, delta selection on options, intrinsic versus extrinsic value, and position sizing based on portfolio growth are all addressed with practical examples. This is real trading talk. Real numbers. Real expectancy metrics. Not vague motivation.The emphasis stays consistent: cut losers short, reduce risk aggressively, let structured signals guide entries and exits. A proven plan showing positive expectancy and a documented win rate around 56.94 percent is what drives execution. If you do not know your expectancy, you do not have a trading plan.If you want to see how this screening process works inside OVTLYR, how signals are evaluated, and how trades are structured in real time, subscribe to the OVTLYR channel for deeper breakdowns, live examples, and risk-managed strategies built for serious traders.

De Brabantse grondafhandelaar Viggo komt in Amerikaanse handen. Goed voor de positie in de race om een plek op Schiphol, maar vakbond FNV is alert. Verder krijgt Schiphol er drie airlines bij (en raakt er eentje kwijt) en wordt het druk in Italië tijdens de Olympische Spelen. Podcast-presentatoren Klaas-Jan van Woerkom en Maarten Veeger bespreken daarnaast de situatie in India, waar Embraer, ATR én de Russen grote plannen hebben, en blikken vooruit naar het komende Luchtvaartnieuws Magazine, dat grotendeels in het teken staat van de Concorde.

En medio de todos los contratiempos e infortunios, Dios está ordenando lo mejor para nuestro futuro. Cada cosa que ocurre en nuestros días está diseñada para acercarnos más a Él y a nuestro propósito. Quizá hoy sientas que estás en el pozo; tú y tu familia, rodeados de fracasos y frustraciones, encarcelados en su propia versión de la cárcel egipcia. Pero Dios ve a un guerrero en ti y hoy te dice: tu familia necesita a un José. Atrévete a ser un mensajero de gracia en un día de rencores y revanchas; un firme eslabón en la cadena de fe. ¡Un mensaje retador!

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.It's freezing outside, markets are wild, and this video is all about staying sharp when everything feels chaotic. The focus here is simple: how to manage trades correctly, how to remove risk without killing upside, and why having a plan matters more than guessing where the market goes next.This conversation is really about what separates people who talk about trading from people who actually do it. Same market. Same information. Same opportunities. The difference is execution. You'll hear a lot about rolling options, taking partial profits, and freeing up capital instead of letting greed or fear dictate decisions. That's not flashy, but it's how consistency is built.A big theme here is discipline. Being up early in the year doesn't mean it's time to press harder. That's usually when traders do the most damage. The approach shown here is about scaling risk down as trades work, not ramping it up just because things feel good. Wins are managed the same way losses are managed, with structure and intention.There's also a strong emphasis on sitting in cash when conditions aren't right. Not trading is still a decision. Waiting for confirmation across trends and signals beats forcing trades just to feel productive. This is where patience actually becomes a competitive advantage.You'll hear practical breakdowns of trend confirmation using the 10, 20, and 50 moving averages, why ATR matters for trade management, and how rolling options can turn a trade into something close to risk-free over time when done correctly. None of this is about prediction. It's about reacting to what the market is actually doing.Key ideas covered in this session include:✅ How rolling options takes risk off while keeping trades alive✅ Why being early isn't as important as being disciplined✅ How trend alignment helps avoid emotional decisions✅ When sitting in cash is the smartest move you can make✅ Why overconfidence after wins is just as dangerous as fear after lossesThere's also a clear reminder throughout the video that losing trades are unavoidable. Anyone chasing a perfect win rate is already off track. The goal is to keep losses small, let winners breathe, and survive long enough for the edge to compound. That's how accounts grow without blowing up.If you're newer, the message is to slow down. Paper trade. Ask questions. Learn the process before risking real money. FOMO hits everyone, but a plan exists to keep emotions from wrecking good decisions.If you want to understand how structured trading actually works in real time, this video gives you a clear look. No hype, no shortcuts, just repetition, patience, and accountability.Subscribe if you want more sessions like this focused on saving time, managing risk, and trading with clarity instead of stress.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Menteri Kelautan dan Perikanan Sakti Wahyu Trenggono dipastikan pulih usai sempat pingsan saat memimpin upacara penghormatan korban insiden pesawat ATR. Staf Khusus KKP Doni Ismanto menjelaskan kondisi terkini, penyebab kelelahan, serta langkah KKP mendampingi keluarga korban. Wawancara Radio Elshinta edisi Siang, 25 Januari 2026.

On this week's episode of AvTalk, the US issues a set of NOTAMs warning of military activity in a large swath of the North Pacific. The NTSB issues an update on the UPS MD-11 crash, focusing on additional materials analysis performed on a bearing from the engine pylon mount. An ATR 42 operating for the […] The post AvTalk Episode 354: Want to buy a 747SP? appeared first on Flightradar24 Blog.

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.The market is getting absolutely wrecked in this session and yet the account is doing the exact opposite. That contrast is the whole point of this video. When chaos hits the tape, most traders panic. This walk-through shows what it looks like to stay calm, follow the plan, and let the system do the work while everyone else is reacting.This is a live breakdown of real trades inside a U.S. Investing Championship account. Every position is marked to market in real time. Every adjustment has a reason. There is no guessing, no gut trades, and no chasing candles. The focus is on managing risk first, then letting returns take care of themselves.You will see how multiple plans can run at the same time without conflict. Plan M is aggressive when conditions are right. Plan ETF steps in when momentum fades. Sitting in cash is not failure, it is a position. The goal is not to always be trading. The goal is to always be aligned with what the market is actually doing.The video walks through reducing risk before adding anything new, which is something most traders skip entirely. Positions are trimmed, rolled, or closed based on signals like ATR movement, order blocks, and moving average crosses. Nothing fancy. Just rules being followed even when emotions want to interfere.Options management plays a big role here. You will see trades rolled up and out for credit, liquidity checked before entries, and extrinsic value evaluated instead of ignored. Small stock moves turn into outsized option gains because leverage is used intentionally, not recklessly. And when a trade violates the plan, it gets closed. No debating it. No hoping.Here are a few key takeaways that really stand out in this session:✅ Why reducing risk comes before adding new trades✅ How Plan M, Plan ETF, and cash can all run together✅ What rolling options for credit actually looks like live✅ Why exit rules matter more than squeezing extra upside✅ How discipline keeps accounts green on red market daysOne of the most important moments is watching a profitable trade get closed simply because it entered an order block. Could it keep running? Maybe. But that does not matter. The plan says close it, so it gets closed. That is how long-term consistency is built. Not by being right all the time, but by being disciplined all the time.By the end of the update, the portfolio is rebalanced, cash is redeployed with purpose, and gains are locked in. No hype. No hero trades. Just clean execution in a rough market.This is the mindset behind the OVTLYR Trading Room and OVTLYR University. Save time. Make money. Start winning with less risk. If you want to see what real trade management looks like when the market is ugly, this video delivers.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.Markets are freaking out, headlines are loud, and price is swinging all over the place. One day the market is down hard, the next day it rips higher. That's exactly why this video matters. Instead of panicking, guessing, or reacting emotionally, this is a real look at how a professional investor stays calm, sticks to the plan, and trades through chaos with confidence.In this session, you're watching real trades being managed in real time during extreme volatility. Nothing is cleaned up, nothing is hidden, and nothing is sugarcoated. You'll see how positions are marked to market, how rolling trades actually works in practice, and why not every red candle is a reason to bail. This is what disciplined trading looks like when the market is trying to shake everyone out.One of the biggest takeaways is how much damage panic selling does to most traders. The conversation keeps coming back to the same core idea over and over. You only get paid if price goes up. Everything else is noise. Fundamentals, opinions, headlines, and hot takes do not matter if the trend is working against you. Price always gets the final vote.There's also a deep dive into risk management and position sizing. Volatility matters. ATR matters. You'll see exactly why volatile stocks require smaller size, how risk is reduced without exiting trades prematurely, and how rolling positions can take pressure off when price moves against you. This is the kind of stuff most people never learn because they are too busy chasing the next prediction.To make things easy to follow, here are some of the key ideas covered in the video:✅ Why panic selling usually locks in losses instead of protecting you✅ How trend signals actually work when markets get wild✅ Why volatility and ATR should control position size✅ How rolling trades can reduce risk instead of adding it✅ Why buying dips can destroy accounts in downtrendsThe video also gets into some classic Wall Street disasters and viral finance moments. Hedge funds blowing up. Media appearances gone wrong. Traders getting wiped out by leverage, ego, or ignoring simple rules. These stories are not just entertainment. Each one connects back to a lesson about discipline, humility, and respecting risk. The market does not care who you are or how smart you think you are.Transparency is a big theme throughout. Trades are shown live. The portfolio manager is open. The numbers are real. The goal is not hype or flashy promises. The goal is showing what it actually looks like to follow a rules based system day after day, especially when emotions are running high.If you've ever felt overwhelmed by market noise, tempted to sell at the worst possible moment, or confused by conflicting opinions online, this video brings everything back to basics. Follow the plan. Respect the trend. Control risk. Let price do the talking.If you want to save time, make smarter decisions, and learn how disciplined trend trading actually works using OVTLYR tools, this walkthrough gives you a clear, honest look at the process from the inside.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

¡No todos los días se puede brillar! Atrás quedaron las fiestas de diciembre y las vacaciones, y ahora debes pensar en el estudio o el trabajo y pagar tus obligaciones. ¿Cómo afrontar la tristeza del tercer lunes del año? La terapeuta Perla de la Rosa te explica cómo afrontar la cuesta de enero. Es tiempo de agradecer y disfrutar el Año Nuevo 2026 escuchando Por el Placer de Vivir con el Dr. César Lozano. Disponible en Uforia App, Apple Podcasts, Spotify, ViX y el canal de YouTube de Uforia Podcasts.¿Cómo te sentiste al escuchar este Episodio? Déjanos tus comentarios, suscríbete y cuéntanos cuáles otros temas te gustaría escuchar en #porelplacerdevivir 

Usai jatuhnya pesawat ATR rute Yogyakarta–Makassar, ruang publik dipenuhi berbagai informasi dan spekulasi. Di tengah duka dan keprihatinan, transparansi menjadi kunci agar publik mendapatkan informasi yang akurat dan tidak menyesatkan. Lalu, langkah apa yang perlu dilakukan otoritas penerbangan dan maskapai untuk mencegah simpang siur informasi? Evaluasi apa saja yang harus dilakukan, mulai dari aspek teknis pesawat, prosedur operasional, hingga pengawasan keselamatan, demi memastikan penerbangan di Indonesia semakin aman ke depan?Talk: - Pemerhati Penerbangan, Andrianus Darmawan- Pengamat Keamanan dan Keselamatan Penerbangan, Marsma TNI (Purn) Agung Sasongkojati

In Indonesien ist am frühen Nachmittag eine ATR 42-500 abgestürzt. Wir fassen die ersten wichtigen Infos für euch zusammen. zu YouTube: https://youtu.be/6WH2CVFWST4

ATR has built an aircraft that should interest U.S. airlines because of its low relative operating costs on short routes. But with larger airlines unwilling to take a chance on a turboprop, ATR is hoping public charter operator JSX will change the market. JSX is testing ATR-42s from Santa Monica, and if it works, it may add more. Jon Ostrower and Brian Sumers recently took a ride on the first JSX turboprop and spoke with the CEOs of JSX and ATR to learn more about this partnership. Reach top leadership and decision-makers at airlines around the world by sponsoring The Air Show. We are currently booking campaigns for 2026. Visit www.theairshowpodcast.com to get in touch with us.

En este episodio del videopodcast Atrévete a Ser, converso con Luis Hernández, CEO de Corporación Actinver, sobre el dinero como una herramienta que revela quiénes somos y hacia dónde vamos.Hablamos del papel clave que hoy tienen las mujeres en las finanzas, de liderazgo empático, de romper inercias y de entender el dinero como poder consciente y responsabilidad. Te invito a escuchar esta conversación como una pausa para mirar tu relación con el dinero y con la forma en que tomas decisiones.Este episodio llega a ti gracias a Actinver, acompañándote a construir las mejores historias de tu vida.¡Hola, soy Elisa Queijeiro!Nací para contar historias. Soy humanista, escritora y académica, pero sobre todo, soy una mujer hambrienta de aprender. Descubrí que las verdades del pasado pueden inspirarnos hoy si las sabemos escuchar.

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.This video drops you straight into a live trading session where real decisions are being made with real money on the line. No hindsight. No cherry-picking. Just walking through how trades are actually evaluated, filtered, and executed inside a U.S. Investing Championship portfolio.The session kicks off by laying out the context. This is Plan M, the most aggressive plan in the playbook. That matters because nothing gets added unless the market, the sector, and the stock are all aligned. Before even thinking about new trades, existing positions are reviewed first. If something needs to be reduced or closed, that happens before adding risk. That step alone separates disciplined traders from reactive ones.From there, the focus zooms out to the market. Trend structure, moving averages, ATR levels, and fear and greed data are all checked to see if the environment actually supports taking risk. The goal is not to predict. It's to listen to what the market is already saying. If the market is not in a position to support aggressive trades, nothing gets forced.Once the market looks solid, attention shifts to the sector level. This is where relative strength starts to matter. Sectors showing rising momentum, bullish breadth, and improving fear and greed scores move to the front of the line. Everything else gets ignored. Simplicity wins here.Only after those boxes are checked do individual stocks come into play. Each candidate is run through strict criteria around trend, buy signals, price levels, distance from order blocks, and liquidity. If even one piece doesn't line up, the trade is skipped without hesitation. There is zero emotional attachment to any ticker.You also get a clear look at how patience works in real time. Some setups are ready immediately. Others look promising but need more time to confirm. Instead of guessing, they're put on watch and revisited later. Waiting is part of the strategy, not a mistake.When a trade finally goes on, every step is intentional. Liquidity is checked first. Delta selection is deliberate. Extrinsic value is calculated. Position size is determined based on predefined risk, not gut feel. If capital is needed, it's raised by trimming existing positions rather than overextending the account.Here are some of the biggest takeaways from this session:✅ How Plan M stays aggressive without blowing up risk✅ Why market and sector alignment come before stock selection✅ How fear and greed data is used as confirmation, not prediction✅ What real liquidity rules look like when trading options✅ How entries, exits, rolls, and emergency stops are planned in advanceOne of the most important parts of this video is seeing trades marked on the chart immediately after entry. Entry zones, roll levels, stop losses, and emergency exits are defined upfront. That way, decisions don't have to be made under pressure later. This is how emotion gets removed from the process.If you've ever wondered what a professional, rules-based trading workflow actually looks like while the clock is running, this session shows it clearly. It's not flashy. It's not rushed. It's methodical, disciplined, and repeatable. That's the real edge.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Los productores tabasqueños Ángel Mario Herrera González y José Madrigal explican en qué consiste su nueva apuesta musical a celebrarse el próximo 31 de enero. ¿Cuántos artistas participan en ella? ¿Es cultural? ¿Cuántas funciones tienen garantizadas? ¿Buscarán llevarlo a todo el estado? Atrévete a conocerla aquí.

En este episodio del videopodcast Atrévete a Ser de Elisa Queijeiro, conversamos con Ana Victoria García, emprendedora, inversionista y fundadora de Victoria147, una academia de negocios que ha acompañado a miles de mujeres a profesionalizar sus proyectos y construir emprendimientos con impacto social.Ana Victoria estudió Mercadotecnia y Administración de Negocios en la Universidad Anáhuac, trabajó en Endeavor México apoyando a emprendedores de alto impacto y, en 2012, decidió fundar Victoria147 para demostrar que el propósito y la rentabilidad no están peleados.En esta conversación, Elisa y Ana Victoria hablan de cambiar de rumbo, asumir riesgos, construir comunidad, maternar sin renunciar a la vida profesional y convertir una pasión en un proyecto real y sostenible. Una charla honesta sobre disciplina, vulnerabilidad y visión a largo plazo.Este episodio llega a ti gracias a Actinver, acompañándote a construir las mejores historias de tu vida.¡Hola, soy Elisa Queijeiro!Nací para contar historias. Soy humanista, escritora y académica, pero sobre todo, soy una mujer hambrienta de aprender. Descubrí que las verdades del pasado pueden inspirarnos hoy si las sabemos escuchar.

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.If you have ever felt like trading gets way more complicated than it needs to be, this session is going to hit home. This class is all about money management, risk, and why most traders struggle not because they lack setups, but because they never learn how to protect their capital.The big idea here is simple but uncomfortable. Winning trades are inevitable. Losing trades are also inevitable. The difference between traders who survive and traders who blow up is not prediction skill. It is how well risk is controlled when things go wrong. That is the entire foundation of this lesson.You will hear why managing money is really just managing risk. Once risk is out of control, the account is out of control. It does not matter how good the strategy looks, how confident you feel, or how exciting the trade sounds. Without structure, losses compound fast and emotions take over even faster.This session walks through why most traders focus on the wrong things. Amateurs obsess over upside and hate taking losses. Professionals focus on process, discipline, and position sizing. The money shows up as a byproduct of doing those things consistently, not the other way around.A major focus of this lesson is Monte Carlo simulation and why it matters in the real world. Instead of asking what the most likely outcome is, the better question is how bad can this get. If the worst case scenario still works, the plan is solid. If the worst case scenario wipes you out, the plan is broken no matter how good it looks on a chart.Along the way, you will see live examples of expectancy, win rates, loss rates, and why taking more trades actually reduces randomness over time. You will also hear why ignoring stops, doubling down, or hoping a trade comes back is one of the fastest ways to destroy an edge.Here are a few core ideas that really stand out in this class:✅ Why risk control matters more than finding perfect entries✅ How Monte Carlo simulations reveal hidden danger in trading plans✅ The difference between position sizing and portfolio sizing✅ Why consistent risk matters more than consistent share counts✅ How ATR-based sizing keeps losses predictableThe lesson also breaks down position sizing step by step using volatility instead of gut feel. Instead of guessing how much to buy, risk is calculated first and position size becomes a math problem, not an emotional decision. This is where most traders realize how random their past sizing really was.There is also an important conversation about scaling. Jumping from small risk to big risk feels exciting, but it can erase months of progress in a single trade. Scaling gradually is not about fear. It is about giving your edge time to work without blowing yourself up emotionally or financially.Throughout the session, losses are treated as part of the game, not something to avoid at all costs. The goal is not to eliminate losing trades. The goal is to make sure losses are small, controlled, and survivable so winning trades can do their job over time.This is part of OVTLYR University, where the focus is saving time, managing risk, and building trading systems that work in the real world, not just in theory.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.If you have ever woken up to a big market gap and thought, “Okay… now what?” this video is for you. The whole conversation is about how to handle a gap up after a major economic report without panicking, chasing price, or doing something you regret five minutes later. Instead of hot takes or hype, this walks through how a professional actually thinks about these situations using a clear, rules-based plan.The big takeaway is simple but powerful: you do not need to do something just because the market moved. A gap up can feel exciting, stressful, or both, but that emotion is exactly what gets most traders into trouble. This breakdown shows how trend structure, moving averages, and volatility filters work together to tell you whether a gap actually changes anything or not.You will see how a bullish trend is defined using the 10, 20, and 50 EMA, and why short-term pullbacks inside that trend are normal. There is a great explanation of why trends can stay intact for weeks or even months, and why trying to jump in front of them usually backfires. The focus stays on reacting to real data instead of guessing what “should” happen next.One of the strongest themes here is that trading should feel boring. Not dull in a bad way, but boring in the same way brushing your teeth is boring. You have a process, you follow it, and you move on with your day. If trading feels exciting, that is usually a sign something is off.Midway through, the video gets very practical and walks through how the current plan is structured, how backtesting supports it, and how tools like fear and greed heatmaps, ATR levels, and order blocks help remove bias. Everything ties back to having clear rules for entry, holding, and exits.Key ideas covered include:✅ How to tell if a gap up actually matters or not✅ Why holding a position is often the correct move✅ How fear and greed levels impact trade difficulty✅ What order blocks are and how they act as support and resistance✅ Why exits should be planned before you ever enterThere is also a very approachable explanation of options concepts like extrinsic value, bid-ask spreads, and why paying too much for uncertainty quietly eats away at performance. Even if you are mostly a stock trader, these concepts help sharpen risk awareness across the board.Later, the conversation zooms out to the bigger picture. Losing streaks, Monte Carlo analysis, and expectancy are discussed in a way that makes it clear why losses are not a failure, they are part of the deal. The difference between amateurs and professionals is not avoiding losses, it is knowing exactly how to survive them.If you are trying to trade with less stress, fewer impulsive decisions, and more consistency, this video lays out a mindset that actually holds up over time. It is not about prediction. It is about execution, patience, and letting the math do the heavy lifting.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

  «Además, su fe no flaqueó al considerar su cuerpo, que estaba ya como muerto (pues ya tenía casi cien años), o la esterilidad de la matriz de Sara. Tampoco dudó, por incredulidad, de la promesa de Dios, sino que se fortaleció en la fe y dio gloria a Dios» (Romanos 4:19-20) Durante todos los años que he vivido por fe, he aprendido a hacer algo que me ayuda a recibir de Dios en las situaciones más difíciles. Lo llamo: "saltar la línea de la fe". Necesitas una línea de la fe cuando quieres que Dios haga lo "imposible" en tu vida. Es lo que necesitas cuando requieres mantenerte firme en la fe, y aun así sigues como un vaivén, de aquí para allá entre tu situación y las promesas de Dios ―creyendo primero una cosa y después otra―. Eso es lo que puede hacerte semejante al fiel Abraham. En la práctica, Él tuvo que lidiar con factores naturales tal como nosotros tenemos que hacerlo. Él sabía que no había forma natural de que la promesa de Dios se cumpliera. Sin embargo, la Palabra dice que Abraham no consideró su cuerpo, sino que se limitó a creer la promesa de Dios. En otras palabras, él ignoró la evidencia natural y creyó solamente en la promesa de Dios. En un momento dado, él saltó la línea de la fe. Tomó la decisión irreversible de confiar en la Palabra de Dios. Hizo un compromiso final. Decidió dar un paso adelante y nunca más mirar atrás. Si tú y yo queremos que Dios haga lo imposible en nuestra vida, tendremos que seguir el ejemplo de Abraham. Pero, ¿cómo saltas esa línea de la fe? Empieza con la Palabra de Dios. Busca las promesas de Dios y a propósito cree en tu corazón lo que Él ha dicho, y está diciendo, acerca de lo que necesitas. Medita en esas promesas hasta que la fe crezca en tu corazón. Luego, traza la línea de la fe; hazlo en tu mente, en tu corazón. Trázala en el piso, en tu lugar de oración. Luego di: "En la presencia de Dios y de todos los ángeles en este lugar, y en la cara del diablo, estoy saltando la línea de la fe. Desde este momento, considero resuelto este asunto y le doy a Dios la alabanza y la gloria. En el nombre de Jesús". A partir de ese instante, empieza a hablar como si ya hubieras recibido tu milagro. Dale la espalda a los problemas y a las dudas y focaliza tu mirada en Jesús. Dios hará lo imposible en tu vida. Atrévete a saltar la línea de la fe. Lectura bíblica: Romanos 4:13-21   © 1997 – 2019 Eagle Mountain International Church Inc., también conocida como Ministerios Kenneth Copeland / Kenneth Copeland Ministries. Todos los derechos reservados.

Have you put yourself aside for years? In this episode, I talk with Jen Berlingo, LPC, ATR about tuning back into your inner calling and… • Emerging in midlife and unmasking to be your full self again  • Looking inward to identify what needs to change • Navigating big life changes and taking one small step forward at a time • Turning your ear back inward to listen to your inner yearnings and reclaiming your true nature • Assessing whether your lifestyle supports your sensitive nervous system  • Learning to assert your preferences in a world that's not built for HSPs  • Stop abandoning yourself and people pleasing to make others comfortable  Jen (she/her) is a midlife coach, a Licensed Professional Counselor, a Nationally Registered Art Therapist, and a master-level Reiki practitioner. After two decades of midwifing hundreds of women through life's major transitions and experiencing her own passage through a fiery midlife portal where she more fully stepped into her queer identity, she was inspired to write Midlife Emergence to accompany other women in traversing their midlife journeys. Upon its publication, Midlife Emergence reached #1 in several Amazon categories, including midlife management, divorce, LGBTQ+ memoirs, LGBTQ+ parenting and families, adulthood and aging, and self-help. Jen is also a visual artist who not only created the painting on the cover of her book, but also makes custom pieces for collectors worldwide and exhibits her fluid, abstract art locally in her beloved town of Boulder, Colorado.  Keep in touch with Jen: • Website: https://jenberlingo.com • Substack: https://jenberlingo.substack.com  • Instagram: https://www.instagram.com/jenberlingo   • Facebook: https://www.facebook.com/jenberlingotherapy  • Etsy Shop: https://www.etsy.com/shop/artsorceress  Additional Resources: • Get support when undergoing profound transitions like midlife, divorce, or coming out later in life. Learn more + sign up for a free discovery call with Jen at https://jenberlingo.com/coaching  • Midlife Emergence Book: https://jenberlingo.com/book  • 100 Day Project: Thanks for listening! You can read the full show notes and sign up for my email list to get new episode announcements and other resources at: https://www.sensitivestories.comYou can also follow "SensitiveStrengths" for behind-the-scenes content plus more educational and inspirational HSP resources: Instagram: https://www.instagram.com/sensitivestrengths TikTok: https://www.tiktok.com/@sensitivestrengths Youtube: https://www.youtube.com/@sensitivestrengths And for more support, attend a Sensitive Sessions monthly workshop: https://www.sensitivesessions.com. Use code PODCAST for 25% off. If you have a moment, please rate and review the podcast, it helps Sensitive Stories reach more HSPs! This episode is for educational purposes only and is not intended as a substitute for treatment with a mental health or medical professional. Some links are affiliate links. You are under no obligation to purchase any book, product or service. I am not responsible for the quality or satisfaction of any purchase.

Tú también puedes tener una vida plena y con sentido gracias al Desarrollo Personal. Apúntate gratis a la formación gratuita #TransformaTuVida en https://rb.gy/1juq6i Sergio Fernández comparte en esta conferencia dos de las principales habilidades comerciales. Algo imprescindible para los emprendedores ya que el 85% de sus proyectos fracasan ante de los 5 años por no saber como implementar de forma efectiva un Elevator Pitch y tener un buen Storytelling. Accede gratis a más de 500 vídeos y 700 artículos sobre desarrollo personal y profesional en http://www.pensamientopositivo.org. En Instituto Pensamiento Positivo tenemos la misión de divulgar y democratizar inspiración, conocimientos y claves prácticas de desarrollo personal y profesional para que las personas puedan disfrutar de vidas más plenas y significativas. Atrévete a cambiar el rumbo de tu vida profesional y personal con nuestras formaciones presenciales y online: Máster de Emprendedores (presencial y online) https://www.masterdeemprendedores.com/ Máster de Desarrollo Personal https://www.masterdedesarrollopersona... Seminario para emprendedores Vivir sin Jefe (presencial y online) https://www.pensamientopositivo.org/c... Seminario de finanzas personales Vivir con Abundancia (presencial y online)https://www.pensamientopositivo.org/c... Seminario Vivir con Propósito (presencial y online) https://www.pensamientopositivo.org/s... Club de emprendedores Mastermind https://www.pensamientopositivo.org/m... Disfruta de más 700 entradas y más de 500 vídeos sobre desarrollo personal y profesional en http://www.pensamientopositivo.org Descubre más claves prácticas y herramientas para el emprendimiento, las finanzas personales y el desarrollo personal en nuestras redes sociales: Instagram / institutopensamientopositivo Facebook / institutopensamientopositivo Twitter / sergi_fernandez LinkedIn / instituto-pensamiento-positivo https://www.ivoox.com/escuchar-pensamiento-positivo-oficial_nq_90_1.html Sergio Fernández es emprendedor, conferenciante y escritor. Es autor de "Vivir sin jefe", "Vivir sin miedos", "Vivir con abundancia", “Libertad Financiera” y coautor de "Misión Emprender", "El Sorprendedor" y del juego de mesa "Sorprendedores". Dirige el Master de Emprendedores https://www.masterdeemprendedores.com, el Máster de Desarrollo Personal, https://www.masterdedesarrollopersonal.com, el Seminario Intensivo para emprendedores Vivir sin Jefe: https://www.pensamientopositivo.org/intensivo-vivir-sin-jefe/ y el Seminario Intensivo sobre finanzas personales Vivir con Abundancia https://www.pensamientopositivo.org/vivirconabundancia Puedes contactarnos en hola@institutopensamientopositivo.com y conseguir más información en https://www.pensamientopositivo.org

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.In a dynamic landscape marked by both advancements and challenges, the pharmaceutical and biotech sectors continue to evolve with notable scientific, regulatory, and strategic updates. Ipsen's recent $1 billion acquisition of Simcere's preclinical LRRC15-targeting asset underscores a growing focus on antibody-drug conjugates (ADCs). These conjugates leverage the targeted action of antibodies combined with the cytotoxic effects of drugs, representing a promising approach to cancer treatment by potentially minimizing systemic toxicity. Ipsen's strategic move reflects its commitment to expanding its oncology portfolio and staying competitive within the rapidly advancing ADC landscape.AstraZeneca has been active in its pursuit of innovative cancer treatments. The company has invested $100 million in Jacobio's clinical-stage pan-KRAS inhibitor, a promising development targeting KRAS mutations prevalent in various cancers. This investment aligns with AstraZeneca's strategy to tackle challenging oncogenic targets. However, their efforts faced a setback as their Phase 3 trial for ceralasertib, an ATR inhibitor for lung cancer, failed to meet its primary endpoint. Despite this setback, AstraZeneca maintains confidence by investing significantly in promising areas like KRAS inhibitors, highlighting the inherent risks involved in pioneering novel therapeutic strategies, particularly those aiming to overcome resistance mechanisms in immuno-oncology.BioMarin has quietly discontinued its liver disease candidate amid a $4.8 billion deal with Amicus. This decision points to the complex nature of pipeline prioritization and resource allocation within high-stakes financial environments. The company's strategic shifts reflect ongoing evaluations of their development priorities in light of evolving market demands.Boehringer Ingelheim has demonstrated a commitment to renal therapeutics with a $448 million investment in Rectify Pharmaceuticals for a preclinical chronic kidney disease program. This partnership seeks to address significant unmet medical needs within kidney disease treatment. Meanwhile, Gilead Sciences has entered into a $35 million licensing agreement with Assembly Biosciences for herpes simplex virus (HSV) assets, diversifying its infectious disease portfolio and expanding its reach within antiviral therapies.Novo Holdings-backed Windward Bio's acquisition of rights to Qyun's clinical-stage immunology bispecifics for $700 million highlights robust activity in the immunology space. Bispecific antibodies are gaining traction due to their ability to target two antigens simultaneously, offering enhanced therapeutic efficacy. This acquisition illustrates ongoing interest in this area as companies seek innovative solutions to complex immunological challenges.The broader industry is also witnessing strategic partnerships such as Aditum Bio's launch of a new biotech venture with Fosun Pharma. This collaboration aims to foster novel therapies through a synergistic blend of biotechnology innovation and pharmaceutical expertise. These alliances reflect an industry trend towards collaborative efforts that leverage diverse strengths to advance therapeutic development.In regulatory news, nine major pharmaceutical companies have reached agreements with the U.S. government to lower certain drug prices in exchange for tariff relief. This development signals ongoing negotiations aimed at balancing drug affordability with industry sustainability amid growing scrutiny over pricing practices.In December 2025, significant developments emerged, impacting scientific innovation, regulatory approvals, mergers, and strategic partnerships across the industry. Notably, the U.S. Food and Drug Administration (FDA) granted early approval to Cytokinetics' MyqorzSupport the show

Tú también puedes tener una vida plena y con sentido gracias al Desarrollo Personal. Apúntate gratis a la formación gratuita #TransformaTuVida en https://rb.gy/1juq6i Sergio Fernández comparte en esta conferencia dos de las principales habilidades comerciales. Algo imprescindible para los emprendedores ya que el 85% de sus proyectos fracasan ante de los 5 años por no saber como implementar de forma efectiva un Elevator Pitch y tener un buen Storytelling. Accede gratis a más de 500 vídeos y 700 artículos sobre desarrollo personal y profesional en http://www.pensamientopositivo.org. En Instituto Pensamiento Positivo tenemos la misión de divulgar y democratizar inspiración, conocimientos y claves prácticas de desarrollo personal y profesional para que las personas puedan disfrutar de vidas más plenas y significativas. Atrévete a cambiar el rumbo de tu vida profesional y personal con nuestras formaciones presenciales y online: Máster de Emprendedores (presencial y online) https://www.masterdeemprendedores.com/ Máster de Desarrollo Personal https://www.masterdedesarrollopersona... Seminario para emprendedores Vivir sin Jefe (presencial y online) https://www.pensamientopositivo.org/c... Seminario de finanzas personales Vivir con Abundancia (presencial y online)https://www.pensamientopositivo.org/c... Seminario Vivir con Propósito (presencial y online) https://www.pensamientopositivo.org/s... Club de emprendedores Mastermind https://www.pensamientopositivo.org/m... Disfruta de más 700 entradas y más de 500 vídeos sobre desarrollo personal y profesional en http://www.pensamientopositivo.org Descubre más claves prácticas y herramientas para el emprendimiento, las finanzas personales y el desarrollo personal en nuestras redes sociales: Instagram / institutopensamientopositivo Facebook / institutopensamientopositivo Twitter / sergi_fernandez LinkedIn / instituto-pensamiento-positivo https://www.ivoox.com/escuchar-pensamiento-positivo-oficial_nq_90_1.html Sergio Fernández es emprendedor, conferenciante y escritor. Es autor de "Vivir sin jefe", "Vivir sin miedos", "Vivir con abundancia", “Libertad Financiera” y coautor de "Misión Emprender", "El Sorprendedor" y del juego de mesa "Sorprendedores". Dirige el Master de Emprendedores https://www.masterdeemprendedores.com, el Máster de Desarrollo Personal, https://www.masterdedesarrollopersonal.com, el Seminario Intensivo para emprendedores Vivir sin Jefe: https://www.pensamientopositivo.org/intensivo-vivir-sin-jefe/ y el Seminario Intensivo sobre finanzas personales Vivir con Abundancia https://www.pensamientopositivo.org/vivirconabundancia Puedes contactarnos en hola@institutopensamientopositivo.com y conseguir más información en https://www.pensamientopositivo.org

¿Quieres descubrir cómo tener el poder para lograr lo que quieres?: En un mundo donde la manipulación es una herramienta cotidiana, la inocencia es similar a la ignorancia. ¿Estás preparado para identificar y defenderte de las tácticas de poder que otros usan en tu contra? Este libro no es una guía sobre ética o buenas intenciones. Es un manual amoral, despiadado y, sobre todo, muy instructivo que destila tres mil años de historia en 48 leyes claras y concisas sobre cómo obtener, estudiar y combatir el poder absoluto. No es una invitación a convertirte en un tirano, sino una herramienta esencial para comprender cómo operan tus enemigos y colegas y reconocer sus acciones maliciosas. Inspirado en las mentes de Maquiavelo y Sun Tzu, aprenderás a: Nunca hacerle sombra a tu superior, siendo invaluable sin ser percibido como una amenaza. Aplastar por completo a tu enemigo para que no pueda volver a desafiarte. Disimular tus intenciones y mantener a todos desinformados. Reconocer y protegerte de la “Tríada Oscura” de la personalidad: líderes narcisistas, maquiavélicos y psicópatas. El poder transforma. Si no estás dispuesto a entender sus reglas, te arriesgas a ser víctima de ellas. Atrévete a descubrir la cruda verdad y aprende a jugar el juego que todos juegan, lo admitan o no.

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.It was one of those market days that makes people panic. Big red candles, ugly price action, and nonstop noise about what is “supposed” to happen next. But this video is about why those days do not need to control your emotions, your decisions, or your account when you actually have a plan.This session walks through what separates reactive traders from disciplined ones. When the market is down hard, most people feel pressure to act, predict, or fix something. What you see here is a very different approach. Instead of guessing bottoms or averaging down blindly, the focus stays on trend structure, signals, expectancy, and risk control. When you know exactly what you are waiting for, the stress drops dramatically and the decision-making becomes simple.A big theme in this video is psychology. Watching price move without a framework feels chaotic. Once you understand trends, EMAs, ATR, and why exits matter just as much as entries, the market stops feeling random. You do not need to stare at charts all day. You do not need to babysit positions. You just follow the plan and let the data do the heavy lifting.There is also a deep dive into why prediction-based trading fails so many people. Doubling down, hoping, or assuming something has to bounce eventually sounds logical until you realize you never know how far a move can go. This video breaks down why waiting for confirmation puts you in profitable trends faster, with less time underwater and far less emotional damage.Midway through, the discussion shifts into real backtesting data. This is where things get interesting. Instead of “trust me” opinions, you see how expectancy, win rate, ATR behavior, and Monte Carlo testing actually work together. You also learn why some sectors are avoided completely, even if they look tempting, and how frequency and risk-adjusted returns matter more than chasing home runs.Key ideas covered in this video include:✅ Why red days are only scary when you do not have a plan✅ How trend signals remove emotion from trading decisions✅ The role of ATR in defining risk, exits, and expectations✅ Why random trade selection can still work when expectancy is positive✅ How V-shaped recoveries waste time compared to trend confirmationThe bigger takeaway is simple. Trading does not have to be stressful, dramatic, or chaotic. When your rules are clear and tested, you already know what you will do before price ever moves. That clarity is what allows traders using the OVTLYR approach to stay calm while everyone else is freaking out.If you want a calmer, more repeatable way to approach the market that is grounded in data instead of hype, this video is worth your time.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

  «Pero cuando se manifestó la bondad de Dios, nuestro Salvador, y su amor para con los hombres... el cual derramó en nosotros abundantemente por Jesucristo, nuestro Salvador, para que al ser justificados por su gracia viniéramos a ser herederos conforme a la esperanza de la vida eterna» (Tito 3:4,6-7) Un pacto de gracia. Eso es lo que nosotros tenemos con el Dios todopoderoso. Si en realidad entendieras la importancia                                                                                                                                            de este pacto, nunca más serías el mismo. ¿De qué se trata exactamente ese pacto de gracia? Es una relación de favor que te da acceso al poder de otra persona. Una ilustración del pacto de gracia es el pacto que los miembros de las antiguas familias sicilianas tenían con el "padrino" de la "familia". En ese clan, una persona en una situación de desventaja podía pedirle al padrino un favor. El padrino decía: «Te concederé este favor y a cambio te pediré otro. Llegado el momento oportuno, te haré saber cuál será ese favor». Una vez que el padrino decía esas palabras, la persona en desventaja se llenaba de emoción. De repente, sabía que se había quitado un gran peso de encima. Si alguien trataba de causarle problemas, ese alguien tendría que entenderse con el padrino, quien ejercía todo el poder. La actitud de la persona en desventaja cambiaba por completo; salía de la presencia del jefe de la familia con la confianza plena de que no tenía de qué preocuparse. Ya no se veía a sí mismo en su mente pequeño y sin poder. Había obtenido favor (o gracia) con el poderoso. Esa persona se iba pensando: "Todo está arreglado. Sólo debo cumplir lo que el padrino me pida―y él sabe que no tengo nada; así que cualquier cosa que me pida que haga, él proveerá los medios para hacerlo". Eso es gracia: la voluntad de Dios para establecer un pacto de sangre con nosotros mediante el cual nos da todo lo que Él tiene a cambio de todo lo que nosotros tenemos. Él tomó nuestro pecado para entregarnos a cambio Su justicia. Tomó nuestras enfermedades para darnos Su salud. Él tomó nuestra pobreza para suplir todo lo que necesitamos conforme a Sus riquezas en gloria. Siempre que Dios nos pide que hagamos algo, Él pone a nuestro alcance todo lo que necesitamos para hacerlo. El gran Jehová, el Dios del cielo y de la Tierra, es nuestro Padre Dios. ¿Comprendes lo que eso significa? Si estás cubierto por la sangre de Jesús, has sido hecho un hijo de pacto del Ser más poderoso del universo. ¡Atrévete a ocupar tu lugar en la familia! Lectura bíblica: Lucas 4:14-21   © 1997 – 2019 Eagle Mountain International Church Inc., también conocida como Ministerios Kenneth Copeland / Kenneth Copeland Ministries. Todos los derechos reservados.

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.If you've ever wondered why so many options traders blow up their accounts, this video breaks it all down in a way that actually makes sense. The reality is uncomfortable but important. Roughly 90 percent of options traders lose money, not because they're stupid, but because they're trading without a real framework, without position sizing, and without understanding how risk actually works.This walkthrough digs into the real reasons traders fail and what separates disciplined traders from people just chasing screenshots on social media. You'll hear honest explanations about leverage, capital efficiency, psychology, and why getting lucky early can actually be one of the most dangerous things that happens to a trader.Instead of hype or shortcuts, the focus stays on what actually matters long term. Risk per trade. Position sizing using ATR. Why deep in-the-money options can dramatically change the math. Why blowing up an account is common, but not inevitable. And why trading without a plan turns even a high win rate into a losing strategy.There's also a real-world breakdown of how traders get trapped by probability metrics, earnings volatility, and false confidence. The Palantir example alone is a masterclass in how “high probability” trades can still wipe you out if you don't understand context, expected moves, and event risk.Midway through the video, things get practical fast. You'll see exactly how the same dollar risk can be applied across wildly different stocks, from slow movers to high-flyers, without gambling the entire account. This is where capital efficiency becomes a weapon instead of a liability.Here's what you'll walk away with:✅ Why most traders lose money even with “good” strategies✅ How proper position sizing keeps losses survivable✅ The real role of ATR in defining risk, not profit✅ Why deep in-the-money options change the leverage equation✅ How emotions quietly destroy accounts without traders noticingThe conversation also gets brutally honest about discipline. Cutting losers. Avoiding FOMO. Not doubling down out of hope. Following a predefined plan even when it feels uncomfortable. This isn't about winning every trade. It's about staying in the game long enough for an edge to actually work.If you're serious about trading, this isn't motivational fluff. It's a reality check paired with a framework that prioritizes survival first, consistency second, and growth last. That mindset shift alone can be the difference between blowing up and building something sustainable.This video is especially valuable if you're new to options, transitioning from paper trading, or struggling to understand why your results don't match your win rate. It connects the dots between math, psychology, and execution in a way most trading content avoids.Watch it all the way through, take notes, and revisit the sections on risk and position sizing. These concepts compound over time, just like bad habits do if they're ignored.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

En este episodio platicamos con la Gerente de producto de la marca Lynk & Co, con quien viajamos a China para conocer más de cerca, es una marca automotriz chino-sueca fundada en 2016, resultado de una colaboración entre Geely Auto Group y Volvo Car Group. Su objetivo es crear vehículos innovadores y de alta calidad, combinando la tecnología y seguridad de Volvo con la innovación y diseño chino. Utiliza la plataforma CMA (Compact Modular Architecture), desarrollada conjuntamente con Volvo, que permite una mayor flexibilidad y eficiencia en la producción. Impresionante lo que la marca Lynk & Co ha sido capaz de lograr en tan solo 9 años y han logrado vender 1.62 millones de unidades. Atrévete a conocer más sobre esta marca que seguramente te llamara la atención de inmediato por su tecnología y diseño. 

María creyó antes de ver. Su fe se adelantó nueve meses a la evidencia. Sin embargo, muchos esperan ver resultados antes de confiar, cuando la fe bíblica siempre da el primer paso sin garantías visibles. De modo que hoy sigue el ejemplo de esta joven que, sin entenderlo todo, dijo: “Hágase conmigo conforme a tu palabra”. Además, la fe que se adelanta al milagro no es impulsiva; es obediente. Surge en corazones que escuchan, se rinden y responden sin exigir explicaciones. Así pues, piensa en una área de tu vida donde Dios te está llamando a confiar antes de ver: una relación que necesita restauración, una decisión que requiere valentía o un sueño que parece imposible. Atrévete a creer antes del resultado. Los milagros suelen comenzar con un “sí” que honra a Dios más que a la lógica visible. La Biblia dice en Lucas 1:45: “Bienaventurada la que creyó, porque se cumplirá lo que le fue dicho de parte del Señor”. (RV1960).

En este podcast, escuchamos el debut de Violet Grohl -hija de Dave Grohl- y también a Tomora, nueva aventura de Tom Rowlands, de The Chemical Brothers, y Aurora. Aparte, escuchamos a Audrey Hobert, a Guv, a Channel Tres y a Ruthven-. XOEL LÓPEZ - Sombras ChinasCAROLINA DURANTE - Joderse La VidaBARRY B, CAROLINA DURANTE - Yo Pensaba Que Me Había Tocado DiosALCALÁ NORTE - SupermanCAMELLOS - CamónLEIVA, ROBE - Caída LibreEXTREMODURO - La Vereda de la Puerta de AtrásAUDREY HOBERT – Sex and the CityGUV - Warmer Than GoldVIOLET GROHL - ThumFOO FIGHTERS - The BestRUTHVEN - Precognition AMBER MARK ft ANDERSON.PAAK - Don't Remind MeCHANNEL TRES - En Vogue - Free Your MindTOMORA - Ring The AlarmROSALÍA - PorcelanaROBYN - Dopamine (Jamie xx Remix)Escuchar audio

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.If you have ever wondered why so many traders get crushed trading options, this breakdown will hit hard. In this video, we walk through a real conversation about the truth behind options trading, why most retail traders struggle, and how a smarter, data-driven approach can tilt the odds in your favor. There are wild stories here, from someone turning 88,000 dollars into 415 million only to lose it all, to the hard reality that over 75 percent of option trades lose money for most people. It is intense, but also eye opening.This isn't just a warning. It is a deep dive into the difference between gambling disguised as trading and actually having a systematic plan that gives you a real edge. You will see why embedded leverage can be both powerful and dangerous, how retail behavior resembles a casino more than an investment strategy, and what it actually takes to flip the script. If you have been treating options like a video game or chasing hype trades, this is the reality check you need.And yes, OVTLYR University comes up a lot because the whole point is helping traders shortcut the painful learning curve. When you understand risk, expectancy, and what real planning looks like, everything changes. You stop acting like a gambler and start acting like someone with a repeatable framework for wealth building.Here are a few standout moments from the video:✅ Why a 70 percent win rate can still destroy a trading account✅ How expectancy actually determines long term success✅ The real reason retail traders blow up accounts within 90 days✅ What systematic, backtested rules look like in practice✅ Why complex multi leg strategies often have negative expectancyThe conversation gets into hedging, bid ask spreads, expectancy math, backtesting insights, and even how emotional cycles like euphoria and denial trap most traders into buying at the top and panic selling at the bottom. You'll also hear a candid breakdown of strategies that seem smart but fail in real life, like iron condors with high win rates that still lead to massive losses. The honesty here is refreshing, especially compared to the hype driven content that floods the internet.This video also touches on the reality of watching successful traders online. Seeing someone win can trick you into taking more risk without understanding the downside. But when you have a real trading plan, you learn how to enter, exit, size your position, and respond to volatility instead of reacting emotionally. The message is simple: trading should be boring. If it feels exciting, you are probably doing something wrong.There is also a practical section showing how to use ATR, how to roll positions correctly, how to manage order blocks, and how to avoid adding unnecessary risk. These are the small details that separate consistent traders from the crowd that keeps blowing up accounts.If you want a smarter, more disciplined way to approach options trading, this walkthrough is going to help you see exactly where most people go wrong and how you can avoid the same traps.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.Trades like this are the kind you remember. You put the position on, follow the plan, and it just takes off. In this OVTLYR Trading Room session, you get a front row seat to exactly how those trades unfolded, why the rolls were taken, how the risk was cut, and what signals kept everything on track. It's real trading in real time, and nothing is sugarcoated.One of the biggest takeaways in this session is how much clarity you gain when you stop stressing over your starting balance and start measuring your performance the right way. Money weighted returns finally make the math match reality, especially when your account has deposits, withdrawals, or both. When the numbers suddenly make sense, everything gets easier.On top of that, the video breaks down how OVTLYR plans operate in fast markets, calm markets, and everything in between. Rolling winners, managing open risk, knowing exactly when not to touch a trade, and using ATR levels to stay grounded are all on full display. And the best part is how simple it becomes once you understand the logic behind every move.Here's a quick snapshot of what you'll pick up:✅ How rolling trims risk while keeping winners alive✅ Why money weighted returns give a more accurate picture of your performance✅ How OVTLYR signals cut out the guesswork most traders struggle with✅ What to look for in trend strength, sector breadth, and order blocks✅ Why a rules-based plan removes stress from red candles and intraday noiseYou'll see trades that have already taken off 40 percent, 50 percent, even 74 percent of their risk, all while staying on because the trend is still holding. You'll also see why liquidity matters when rolling, how extrinsic value influences timing, and how sector confirmation sets the stage for new setups.The conversation also gets into the excitement building around the US Investing Championship and why having a real plan matters more than talking big online. Nothing beats transparent execution backed by data, and that theme carries throughout the entire session.By the end, you'll understand why calm, consistent execution beats hype every single time. You'll see how market breadth, fear and greed levels, and sector strength tell you when conditions are right for new trades. And you'll understand how pro traders think about capital, especially when only a small percentage is available for new opportunities.If you're serious about saving time, making money, and actually winning with less risk, this breakdown shows you exactly how the process works inside the OVTLYR Trading Room. Subscribe so you don't miss the next live session and keep building the skills that separate confident traders from emotional ones.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

«El que antes robaba, que no vuelva a robar; al contrario, que trabaje y use sus manos para el bien, a fin de que pueda compartir algo con quien tenga alguna necesidad» (Efesios 4:28) Siempre me asombra que, cuando predico sobre la prosperidad, alguien se acerca y me dice: "Yo no necesito mucho dinero. Soy una persona sencilla con una vida sencilla. Simplemente le pido a Dios lo suficiente para suplir mis necesidades". Algunos creen que eso significa ser humilde, pero no lo es. ¡Es egoísmo! No lo consideran así, pero en realidad están diciendo: "Lo único que me preocupa es poder cubrir mis necesidades. No tengo deseos de ayudar a satisfacer las necesidades de los demás". Bien, esas personas podrían pedirle a Dios un millón de dólares, usar lo suficiente para cubrir sus necesidades y donar el resto. Pero ni siquiera se les ocurre hacerlo, ya que cuando se trata de dinero, el mundo les ha lavado el cerebro haciéndoles creer que si tienen exceso, deben guardarlo. Esa creencia ha sido un obstáculo para el ministerio de Jesucristo en el mundo de hoy. Ha hecho que ministros del evangelio abandonen su llamado y consigan trabajos seculares para poder subsistir. Esto también ha perjudicado a las iglesias y paralizado el crecimiento de los ministerios que hubieran podido alcanzar miles de almas para el Señor. No hay duda de que se necesita dinero para predicar el evangelio. Jesús lo sabía, y contrario a lo que piensa mucha gente, el ministerio de Jesús no carecía de fondos. Había tanto dinero circulando por Su ministerio que fue necesario nombrar un tesorero: su nombre era Judas. Pero Jesús no acumuló ese dinero para Sí mismo. Lo entregó para cubrir las necesidades de los que le rodeaban. Tal era Su fama de ser generoso que en la noche de la última Cena, cuando Judas salió repentinamente de la habitación, los discípulos creyeron que Jesús lo había enviado a darles a los pobres. ¿Puedes imaginarte lo mucho y las tantas veces que Jesús le había dado a los pobres para que los discípulos dieran ese hecho por sentado? Jesús jamás fundó ningún imperio mundano para Sí. Pero eso no significa que era pobre. Quiere decir que era la persona más generosa que jamás haya existido sobre la faz de la Tierra, y ya es tiempo de que comencemos a seguir Sus pasos. No rechaces la riqueza que Dios quiere darte sólo porque crees que no la "necesitas". Atrévete a aceptarla, y luego repártela con quienes sí la necesitan. Deja de trabajar para vivir y empieza a trabajar para dar… y descubrirás el verdadero propósito de las riquezas. Lectura bíblica: Lucas 12:15-31   © 1997 – 2019 Eagle Mountain International Church Inc., también conocida como Ministerios Kenneth Copeland / Kenneth Copeland Ministries. Todos los derechos reservados.

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.Snow's falling on the markets and the candles are glowing, which makes this one of the most unexpectedly fun trading sessions of the season. This whole video blends holiday energy, real market analysis, and practical trading wisdom in a way that feels equal parts entertaining and useful. If you're here to learn how to stay calm, focused, and consistent in any market environment, you're going to enjoy this one.The session opens with a full-on OVTLYR Christmas vibe, complete with a brand-new holiday song from the community. From there, the conversation shifts into how traders actually stay grounded when price action starts wobbling. Think cold dips, warm breakouts, fast reversals, and all the noise in between. The focus stays on one thing: following a system and trusting the math instead of getting pushed around by emotions.You'll also hear a deep dive into the SoFi move and why even strong setups can suddenly get hit with unexpected news. This part is especially valuable because it highlights what seasoned traders already know and newer traders often forget: position sizing and risk control matter more than any single stock. There's also plenty of talk about Fear and Greed heat maps, sector strength, market breadth, and how all of it ties into plan-based trading inside OVTLYR.To make everything easier to digest, here are a few of the big lessons covered:✅ Why the ten over twenty and price over fifty signals simplify trend following✅ What actually happened with SoFi and how to think about sudden drops✅ How to use sector-level Fear and Greed data to pick your spots✅ The difference in expectancy between plan A and plan M✅ Why disciplined entries, exits, and liquidity rules protect your accountThe energy stays high as the conversation moves into bigger themes like honesty in the trading world, why the U.S. Investing Championship matters, and why transparency sets real traders apart from flashy online personalities. There's also a great discussion about learning the craft properly instead of trying to “fast track” success. Trading rewards patience, repetition, and clarity, and that mindset is at the core of OVTLYR University.You'll also hear practical explanations of ATR, market cycles, liquidity, option roll logic, sector rotations, and how breadth conditions determine which setups deserve attention. Everything is broken down in plain English so you can immediately apply it to your own trading.By the end, the vibe returns to community, mindset, and staying committed to the process. There's another song to close things out, celebrating the grind, the discipline, and the wins that come from following a proven plan. If you want a mix of market guidance, psychology, and the kind of energy that keeps traders coming back every day, this session delivers from start to finish.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.This was one of those trading sessions where everything clicks into place and you get to see what disciplined execution actually looks like in real time. Trades were being managed live, rolls were evaluated step by step, and every decision came back to one thing: follow the plan and protect risk first. No hype. No guessing. Just clean, rule-based trading the way it is supposed to be done.You get a front-row seat to how Plan M works when positions move in your favor. Half ATR hit? Now it is time to evaluate a roll. Full ATR? Same process. Nothing is rushed and nothing is forced. The entire session reinforces one simple truth that most traders ignore. You do not need to predict the market. You need to manage it.What really stands out here is how calm and boring good trading actually is. Positions are checked quickly using the 10 and 20 EMA cross. Order blocks are evaluated. Earnings, gaps, and ATR stops are confirmed. If nothing is triggered, nothing is done. That is not passive. That is professional.In the middle of all the live trade management, there are also some powerful mindset reminders. Your trading has to fit your lifestyle. Some traders watch charts all day. Others only trade at the close. Both can work as long as the rules stay intact. What destroys accounts is emotional decision making, rushing, or bending the plan after the fact.Here is a quick breakdown of what you will see in this session:✅ How rolling works using ATR and extrinsic value to reduce risk without killing upside✅ Why low extrinsic value matters more than chasing perfect strikes✅ How the 10 and 20 EMA cross simplifies exit decisions✅ How order blocks shape both entries and exits✅ Why boring execution beats emotional trading every timeYou also get a full market context check using SPY, sector breadth, fear and greed, and value zones. New trades are only allowed when market structure supports them. If the market score does not confirm, no new trades go on. That restraint alone saves most traders from blowing up their accounts.Another standout moment in this session is the emphasis on consistency with indicators. Using multiple scripts that all show different signals leads to confusion and hesitation. Pick one tool. Learn it deeply. Trust it. Consistency is what builds long-term confidence.You will also hear practical answers to advanced questions like whether rolling earlier in the day makes sense, how to handle brokers that do not support rolling, and how to manually calculate extrinsic value if your platform does not show it. These are the real-world issues traders face, and they are addressed directly and honestly.At the end of the day, this session makes one thing very clear. Trading is not supposed to be flashy. It is supposed to be structured, repeatable, and boring in the best possible way. That is how accounts grow over time.If your goal is to save time, make money, and start winning with less risk, this session shows exactly how that framework is built and executed using OVTLYR tools and disciplined decision making.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.Trading days like this feel like controlled chaos in the best way. Screens are moving, alerts are popping, and decisions are getting made fast. There is no slow build up, no perfect timing. It is just taking what the market gives and managing it the right way. Positions get checked, rules get followed, and capital gets moved with purpose instead of emotion.It starts with looking over what is already on the board. Some trades feel like they should be rolled, but once extrinsic value gets checked, they get left alone. That part matters more than it sounds. Skipping a bad adjustment is just as important as making a good one. When a roll actually makes sense, it gets done for a credit. Risk instantly comes off the table and buying power frees up almost right away. That shift from feeling boxed in to suddenly having flexibility again is one of those things traders really learn to appreciate over time.Then comes trimming the fat. A couple of trades get closed because the reason for being in them is gone. What makes this part interesting is that even with the stock moving against the position, the options still come off for small wins or near breakeven. That is volatility and time decay doing what they do best behind the scenes. It is a great reminder that options are not just about direction. Structure matters just as much.Here are some of the ideas that hit during all of this:✅ Rolling trades at logical ATR levels instead of guessing✅ Refusing to roll for a debit✅ Letting extrinsic value drive decisions✅ Closing trades clean instead of trying to rescue them✅ Keeping dollar risk the same even when contract size changesAfter a couple of rolls and a couple of clean exits, the whole account posture changes. What was fully tied up suddenly has real buying power again. And it does not sit on the sidelines. Fresh trades go on using sector strength, liquidity checks, and volatility-based sizing. One position ends up with over a hundred contracts. Another uses a much smaller number. Same dollar risk on both. That contrast trips people out at first, but it is exactly how volatility-based position sizing is supposed to work.One of the most satisfying parts is watching buying power climb from nearly zero to tens of thousands of dollars without adding a single dollar to the account. No leverage tricks. No new deposits. Just proper trade management creating flexibility again. That capital immediately gets recycled into new setups that follow the same rules as everything else.There is also a bigger mindset shift quietly happening in the background. Risk is not about how big a position looks on the screen. It is about how much dollar exposure is tied to volatility. Two trades can look completely different and still carry the exact same real risk when sized correctly. Once that really clicks, the emotional side of trading starts to quiet down.Everything shown here lines up with the way risk, exposure, and sizing are taught inside OVTLYR University. No hype. No miracle moves. Just structure, rules, and fast decisions backed by data. If fast markets have ever felt overwhelming, this kind of workflow shows how structure keeps everything grounded even when things are moving quickly.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.If trading ever felt confusing, overwhelming, or just plain chaotic, this class is the reset button. This session of OVTLYR University dives into what actually keeps traders alive in the market long enough to win: structure, discipline, and a real trading plan that makes sense in the real world.This is not about chasing fast money or trying to guess the next big move. It is about deciding what you are allowed to trade, when you are allowed to trade it, and how much you are willing to risk before you ever click the buy button. Most traders skip this step. That is why most traders do not last.One of the biggest takeaways from this session is how important liquidity really is. If you cannot get in and out of a trade smoothly, nothing else matters. Open interest, volume, and tight spreads are not technical jargon. They are the difference between freedom and being stuck in a bad trade with no exit.Risk management takes center stage in this lesson, exactly where it belongs. Every position is treated as a cost to find out if a trade will work, not a lottery ticket. Stops exist to protect capital, not pride. One rule stands out above everything else: stops only move in one direction. Up. Never down.Here are a few of the most powerful concepts covered in this class:✅ How to define exactly what you are allowed to trade based on skill and comfort✅ Why liquidity rules protect you from disaster before it ever happens✅ How market conditions decide when you trade, not emotions✅ How to build position size from your stop loss backward✅ Why consistent risk per trade creates long term stabilityPosition sizing through volatility and ATR gets broken down in a way that actually clicks. Instead of risking random amounts on different stocks, each trade is normalized so the dollar risk stays consistent across everything you trade. That means no single trade can secretly sink your account while you are not paying attention.There is also a strong focus on protecting the account first. Not dreams. Not ego. Not fantasy profits. Protect the account. Starting at one percent risk is not playing small. It is playing smart. Scaling too fast destroys more traders than bad entries ever will. Survival is the first win.This session also makes something very clear. No one else is responsible for your rules. No one is coming to save you if those rules get broken. You are in control of what you trade, when you trade, and how much you risk. That responsibility is what turns trading from gambling into a real business.The homework is simple, but not easy. Build your own rules. Do not copy someone else's plan word for word. Learn from frameworks. Borrow what works. But your execution must always be your own.If you want to stop guessing and start trading with confidence, this lesson is required watching.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.Ever heard someone say you can risk just $30 and potentially make hundreds on a single options trade? Yeah, that definitely grabs attention. In this episode, things go deep into one of the most misunderstood areas of options trading: gamma exposure. It sounds complex at first, but it is unpacked step by step in a way that actually makes it click. And once it does, you start seeing why expiration weeks behave the way they do. The session kicks off by breaking down delta and gamma in real, practical terms. Delta shows how much an option moves for every one dollar move in the stock. Gamma shows how fast that delta changes. When gamma is stacked across strikes and expirations, you get gamma exposure, which tells you whether market makers are likely to calm price down or push volatility even harder around certain levels.From there, things get really interesting. You see how positive gamma areas usually lead to choppy, range bound markets where price fades work better. On the flip side, negative gamma zones tend to produce fast, violent moves where momentum strategies shine. This single distinction can completely change how you view a trading week.Once those concepts are clear, the episode applies everything to real expiration levels. Using publicly available gamma data, key strikes are identified where large open interest and dealer positioning could influence price. From those levels, two butterfly trades are built. One risks about $30. The other risks about $80. In both cases, the upside can exceed $800 if price lands right on the target at expiration.Here is the real talk moment though. These trades look amazing on paper. The risk is tiny. The reward is massive. But the profit window is incredibly narrow. You only get paid if price lands inside a tiny range at a very specific moment on expiration day. Miss it by a little and the trade loses. That is why this style of trade is compared to buying a lottery ticket with really precise odds.Midway through the episode, several hard truths are laid out clearly:✅ Why positive gamma environments favor premium selling and fading moves✅ Why negative gamma environments create explosive directional action✅ How dealers influence price near heavy open interest levels✅ Why narrow butterflies can look incredible but are brutally preciseOVTLYR tools show up throughout the session, including the value zone framework, ATR rolling rules, and strict exit signals. You also see how a professional style routine actually looks day to day. Checking positions, confirming rules, and making decisions based on data instead of emotion.The big message here is simple and powerful. The goal is not to predict what big money will do next. The goal is to build a repeatable process that protects capital first and lets profits follow.If gamma exposure, expiration pinning, or asymmetric option trades have ever caught your attention, this episode gives you a grounded, honest look at both the upside and the limitations. No hype. Just real trading logic, real risk, and real expectations.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.Today was one of those rare trading days where everything finally lined up. After sitting in cash and waiting patiently, the portfolio goes nearly all-in across nine different stocks, all driven by market trend, sector strength, and precise options execution. This video walks you through exactly how that transition happens, step by step, in real time.It all starts at the top with the broader market. The S&P 500 trend, market breadth, and the fear and greed readings are the first gates that must open before any capital moves. Once those signals align, the focus shifts to sector rotation. Financials, real estate, and utilities rise to the top while weaker sectors get filtered out. From there, individual stocks are screened using buy signals, price location relative to order blocks, and clean technical structure.Instead of tying up massive capital in shares, this portfolio uses deep in-the-money call options as stock replacement. That allows broad diversification without overexposing the account to one ticker. ATR is used to size positions properly, so volatility controls risk instead of emotion. Every trade has defined risk before the order is ever placed.✅ How market, sector, and stock filters stack together✅ Why deep ITM calls can replace stock✅ How ATR controls position size and stops✅ Why rolling at half ATR reduces downside risk✅ How to stay disciplined when fully invested✅ Why losers are built into every winning systemYou also get a real look at how rolling works in practice. At half ATR, partial risk is removed by rolling contracts forward, which lowers exposure while keeping the trade alive. This is where the strategy becomes truly defensive. It is not about guessing where price will go next. It is about managing risk while letting probability work.This video also pulls back the curtain on what trading really looks like behind the scenes. There is no flashy shortcut here. It is spreadsheets, position sizing, stops, and rules being followed without hesitation. Managing nine positions at once is real work, and you see exactly what that workload looks like. This is the side of trading most people never show.Backtesting confirms the reality. The system includes losers by design. The power comes from cutting losses quickly while allowing winners to expand. The goal is not to win every trade. The goal is to stay consistent when emotions try to get in the way.If you have ever wondered what it actually looks like to go from sitting in cash to being fully deployed with confidence and structure, this video shows the entire process from start to finish. Everything is built around the OVTLYR ecosystem and the tools that support it.Stick around, watch how the entries unfold, and see how exits and rolling protect the portfolio after the fact. This is what trading looks like when a plan is actually being executed.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

Are you looking to save time, make money, and start winning with less risk? Then head to https://www.ovtlyr.com.If you have ever wondered what trading actually looks like when it is done with structure, discipline, and zero drama, this session pulls the curtain all the way back. This is not about chasing headlines or falling in love with random tickers. This is about following a written plan, cutting what no longer fits, and only adding risk when the market, sectors, and signals all line up.The first big takeaway is how existing trades are managed before anything new even enters the picture. Positions that violate the rules get removed. No hesitation. No emotional attachment. That alone is a massive edge most traders never develop. From there, the focus shifts to the overall market environment. Trend structure, breadth, and fear and greed readings decide whether trading is even allowed that day. If the market is not aligned, the answer is simple. Stand down.Once the market earns permission, the process narrows quickly into sector strength. Some areas are hot. Some are not. Capital only flows toward what is actively working. That means weak sectors are filtered out fast while strong ones get deeper attention. This keeps you positioned where momentum actually lives instead of where hope wants to be.You also get a real look at how watchlists are built and cleaned in real time. Stocks move on and off the favorites list strictly based on signals. No guessing. No opinions. Just yes or no. That speed and clarity removes stress and keeps decisions clean.Here is a snapshot of what gets broken down:✅ How rule based exits remove fear and second guessing✅ How market and sector alignment filter bad trades fast✅ Why boring trades usually outperform exciting ones✅ How order blocks and ATR guide smarter risk control✅ How option contracts are selected using liquidity, delta, and extrinsic valueThe options section is especially eye opening. Instead of random strikes and expirations, the focus stays on tight bid ask spreads, solid open interest, controlled extrinsic value, and higher delta contracts. The goal is not gambling. The goal is structured leverage that behaves with the stock instead of against it.Throughout the session, one message keeps getting reinforced. Have a plan. Execute the plan. Do nothing that breaks the plan. Trading is treated like a business, not a thrill ride. If it feels exciting, something is probably wrong. The most consistent profits come from repeating boring, high probability actions over and over.You also see how rolling positions reduces risk while freeing up capital for new opportunities, how favorites lists simplify decision making, and how exits are visually automated so there is never confusion about what to do next. Even the discussion around hot sectors reinforces an old but powerful idea. You want to be where momentum is already flowing, not where you wish it would go.If you are tired of emotional trading, overtrading, and mixed signals, this session gives you a cleaner way forward. It shows how professionals think, how they filter noise, and how they stay consistent without the stress.Gain instant access to the AI-powered tools and behavioral insights top traders use to spot big moves before the crowd. Start trading smarter today

En el lado más oscuro de la historia española se esconde una figura que hiela la sangre: “El Arropiero”. De Sevilla a Barcelona, de Marsella a París, Manuel Delgado Villegas cruzó fronteras dejando tras de sí decenas de víctimas, engañando a la policía, confundiendo a psiquiatras y sembrando el terror en cada rincón. Nadie supo jamás si fue monstruo desde la cuna o si lo forjó el abandono y la miseria. Lo cierto es que sus crímenes, espantosos y casi inverosímiles, siguen sin respuesta décadas después. ¿Puede el mal nacer en un hombre… o es el reflejo implacable de aquello que ocultamos bajo la superficie? Atrévete a mirar de frente esta historia: no es solo el relato de un asesino, es el eco oscuro de una época en la que la frontera entre víctima y verdugo podía ser tan tenue como una sombra en la noche. Hoy en Los Sábados Mando Yo…El Arropiero: El hombre tras la leyenda. ¡DALE LIKE AHORA si te fascina el True Crime! ¡SUSCRÍBETE Y ACTIVA LA CAMPANITA! → https://www.youtube.com/@lossabadosmandoyo?sub_confirmation=1 ¿Qué otro asesino serial deberíamos investigar? ¡COMENTA ABAJO! ¡COMPARTE con amigos fans del misterio! ENLACES DE REFERENCIA https://www.reddit.com/r/serialkillers/comments/1gp1nlw/manuel_delgado_villegas_aka_el_arropiero_spains/?tl=es-es https://www.diariodecadiz.es/noticias-provincia-cadiz/arropiero-mayor-asesino-serie-espanol_0_2003211313.html https://www.youtube.com/watch?v=RQxCsI0s1Gw&t=224s ⚠️ ADVERTENCIA: Este contenido incluye descripciones de violencia real y puede no ser adecuado para todos los públicos. Se recomienda discreción. SÍGUENOS EN TODAS LAS PLATAFORMAS: Spotify: https://open.spotify.com/show/7JMeLxFHMtWHEVRGRCY4KO Apple Podcast: https://podcasts.apple.com/es/podcast/los-sabados-mando-yo/id1479960558 iVoox: https://www.ivoox.com/podcast-sabados-mando-yo_sq_f1774095_1.html Telegram: https://t.me/LosSabadosMandoYo Instagram: https://www.instagram.com/lossabadosmandoyo/?hl=es Facebook: https://www.facebook.com/Lossabadosmandoyo/ Twitter: https://x.com/sabadosmandoyo TikTok: https://www.tiktok.com/@lossabadosmandoyo

Querida Libertad, el gran regalo, porque ella dijo al fin “desactivado", la secretaria vil al otro lado. Divina Libertad, los conjurados, aquel dia, por fin, me la entregaron. Despedidos del mundo, hoy celebramos la Libertad querida, afortunados. Atrás quedan al fin los confinados en disfrute feliz de sus mazmorras, no dejaron que el aire penetrara, atrancaron puertas y ventanas. Cadáveres al fin, que hacen pasillos, hablándole al silencio y a los grillos, dispuestos a servir de conejillos en la mesa del dueño de la granja. Aqui puro Babel bien temperado, De música sin fin y verso alado. Un limpio puntocom aqui clavado para la libertad y liberado. Puedes hacerte socio del Club Babel y apoyar este podcast: mundobabel.com/club Si te gusta Mundo Babel puedes colaborar a que llegue a más oyentes compartiendo en tus redes sociales y dejar una valoración de 5 estrellas en Apple Podcast o un comentario en Ivoox. Para anunciarte en este podcast, ponte en contacto con: mundobabelpodcast@gmail.com.

En este episodio del videopodcast Atrévete a Ser de Elisa Queijeiro, conversamos con la actriz y bailarina Scarlet Gruber. Desde temprana edad, Scarlet mostró inclinaciones artísticas, iniciando su formación en ballet clásico. Sin embargo, una lesión en el tobillo la llevó a retirarse de la danza y a enfocarse en la actuación. ¿Qué significa este cambio de vida y cómo es su profesión actual? ¿Qué retos implica reinventarse completamente? En esta conversación, hablo con Scarlet de adaptabilidad, disciplina y el valor de atreverse a comenzar de nuevo con curiosidad y alma abierta. Encuentra conmigo la importancia de la adaptabilidad, y aprendamos que cambiar de camino no es fallar, sino escucharse con valentía. Este episodio llega a ti gracias a Actinver, acompañándote a construir las mejores historias de tu vida. ¡Hola, soy Elisa Queijeiro!Nací para contar historias. Soy humanista, escritora y académica, pero sobre todo, soy una mujer hambrienta de aprender. Descubrí que las verdades del pasado pueden inspirarnos hoy si las sabemos escuchar.

Dr. Linda Duska and Dr. Kathleen Moore discuss key studies in the evolving controversy over radical upfront surgery versus neoadjuvant chemotherapy in advanced ovarian cancer. TRANSCRIPT Dr. Linda Duska: Hello, and welcome to the ASCO Daily News Podcast. I am your guest host, Dr. Linda Duska. I am a professor of obstetrics and gynecology at the University of Virginia School of Medicine.  On today's episode, we will explore the management of advanced ovarian cancer, specifically with respect to a question that has really stirred some controversy over time, going all the way back more than 20 years: Should we be doing radical upfront surgery in advanced ovarian cancer, or should we be doing neoadjuvant chemotherapy? So, there was a lot of hype about the TRUST study, also called ENGOT ov33/AGO-OVAR OP7, a Phase 3 randomized study that compares upfront surgery with neoadjuvant chemotherapy followed by interval surgery. So, I want to talk about that study today. And joining me for the discussion is Dr. Kathleen Moore, a professor also of obstetrics and gynecology at the University of Oklahoma and the deputy director of the Stephenson Cancer Center, also at the University of Oklahoma Health Sciences.  Dr. Moore, it is so great to be speaking with you today. Thanks for doing this. Dr. Kathleen Moore: Yeah, it's fun to be here. This is going to be fun. Dr. Linda Duska: FYI for our listeners, both of our full disclosures are available in the transcript of this episode.  So let's just jump right in. We already alluded to the fact that the TRUST study addresses a question we have been grappling with in our field. Here's the thing, we have four prior randomized trials on this exact same topic. So, share with me why we needed another one and what maybe was different about this one? Dr. Kathleen Moore: That is, I think, the key question. So we have to level-set kind of our history. Let's start with, why is this even a question? Like, why are we even talking about this today? When we are taking care of a patient with newly diagnosed ovarian cancer, the aim of surgery in advanced ovarian cancer ideally is to prolong a patient's likelihood of disease-free survival, or if you want to use the term "remission," you can use the term "remission." And I think we can all agree that our objective is to improve overall survival in a way that also does not compromise her quality of life through surgical complications, which can have a big effect. The standard for many decades, certainly my entire career, which is now over 20 years, has been to pursue what we call primary cytoreductive surgery, meaning you get a diagnosis and we go right to the operating room with a goal of achieving what we call "no gross residual." That is very different – in the olden days, you would say "optimal" and get down to some predefined small amount of tumor. Now, the goal is you remove everything you can see.  The alternative strategy to that is neoadjuvant chemotherapy followed by interval cytoreductive surgery, and that has been the, quote-unquote, "safer" route because you chemically cytoreduce the cancer, and so, the resulting surgery, I will tell you, is not necessarily easy at all. It can still be very radical surgeries, but they tend to be less radical, less need for bowel resections, splenectomy, radical procedures, and in a short-term look, would be considered safer from a postoperative consideration. Dr. Linda Duska: Well, and also maybe more likely to be successful, right? Because there's less disease, maybe, theoretically. Dr. Kathleen Moore: More likely to be successful in getting to no gross residual. Dr. Linda Duska: Right. Yeah, exactly. Dr. Kathleen Moore: I agree with that. And so, so if the end game, regardless of timing, is you get to no gross residual and you help a patient and there's no difference in overall survival, then it's a no-brainer. We would not be having this conversation. But there remains a question around, while it may be more likely to get to no gross residual, it may be, and I think we can all agree, a less radical, safer surgery, do you lose survival in the long term by this approach? This has become an increasing concern because of the increase in rates of use of neoadjuvant, not only in this country, but abroad. And so, you mentioned the four prior studies. We will not be able to go through them completely. Dr. Linda Duska: Let's talk about the two modern ones, the two from 2020 because neither one of them showed a difference in overall survival, which I think we can agree is, at the end of the day, yes, PFS would be great, but OS is what we're looking for. Dr. Kathleen Moore: OS is definitely what we're looking for. I do think a marked improvement in PFS, like a real prolongation in disease-free survival, for me would be also enough. A modest improvement does not really cut it, but if you are really, really prolonging PFS, you should see that-  Dr. Linda Duska: -manifest in OS. Dr. Kathleen Moore: Yeah, yeah. Okay. So let's talk about the two modern ones. The older ones are EORTC and CHORUS, which I think we've talked about. The two more modern ones are SCORPION and JCOG0602. So, SCORPION was interesting. SCORPION was a very small study, though. So one could say it's underpowered. 170 patients. And they looked at only patients that were incredibly high risk. So, they had to have a Fagotti score, I believe, of over 9, but they were not looking at just low volume disease. Like, those patients were not enrolled in SCORPION. It was patients where you really were questioning, "Should I go to the OR or should I do neoadjuvant? Like, what's the better thing?" It is easy when it's low volume. You're like, "We're going." These were the patients who were like, "Hm, you know, what should I do?" High volume. Patients were young, about 55. The criticism of the older studies, there are many criticisms, but one of them is that, the criticism that is lobbied is that they did not really try. Whatever surgery you got, they did not really try with median operative times of 180 minutes for primary cytoreduction, 120 for neoadjuvant. Like, you and I both know, if you're in a big primary debulking, you're there all day. It's 6 hours. Dr. Linda Duska: Right, and there was no quality control for those studies, either. Dr. Kathleen Moore: No quality control. So, SCORPION, they went 451-minute median for surgery. Like, they really went for it versus four hours and then 253 for the interval, 4 hours. They really went for it on both arms. Complete gross resection was achieved in 50% of the primary cytoreduced. So even though they went for it with these very long surgeries, they only got to the goal half the time. It was almost 80% in the interval group. So they were more successful there. And there was absolutely no difference in PFS or OS. They were right about 15 months PFS, right about 40 months OS.  JCOG0602, of course, done in Japan, a big study, 300 patients, a little bit older population. Surprisingly more stage IV disease in this study than were in SCORPION. SCORPION did not have a lot of stage IV, despite being very bulky tumors. So a third of patients were stage IV. They also had relatively shorter operative times, I would say, 240 minutes for primary, 302 for interval. So still kind of short. Complete gross resection was not achieved very often. 30% of primary cytoreduction. That is not acceptable. Dr. Linda Duska: Well, so let's talk about TRUST. What was different about TRUST? Why was this an important study for us to see? Dr. Kathleen Moore: So the criticism of all of these, and I am not trying to throw shade at anyone, but the criticism of all of these is if you are putting surgery to the test, you are putting the surgeon to the test. And you are assuming that all surgeons are trained equally and are willing to do what it takes to get someone to no gross residual. Dr. Linda Duska: And are in a center that can support the post-op care for those patients. Dr. Kathleen Moore: Which can be ICU care, prolonged time. Absolutely. So when you just open these broadly, you're assuming everyone has the surgical skills and is comfortable doing that and has backup. Everybody has an ICU. Everyone has a blood bank, and you are willing to do that. And that assumption could be wrong. And so what TRUST said is, "Okay, we are only going to open this at centers that have shown they can achieve a certain level of primary cytoreduction to no gross residual disease." And so there was quality criteria. It was based on – it was mostly a European study – so ESGO criteria were used to only allow certified centers to participate. They had to have a surgical volume of over 36 cytoreductive surgeries per year. So you could not be a low volume surgeon. Your complete resection rates that were reported had to be greater than 50% in the upfront setting. I told you on the JCOG, it was 30%. Dr. Linda Duska: Right. So these were the best of the best. This was the best possible surgical situation you could put these patients in, right? Dr. Kathleen Moore: Absolutely. And you support all the things so you could mitigate postoperative complications as well. Dr. Linda Duska: So we are asking the question now again in the ideal situation, right? Dr. Kathleen Moore: Right. Dr. Linda Duska: Which, we can talk about, may or may not be generalizable to real life, but that's a separate issue because we certainly don't have those conditions everywhere where people get cared for with ovarian cancer. But how would you interpret the results of this study? Did it show us anything different? Dr. Kathleen Moore: I am going to say how we should interpret it and then what I am thinking about. It is a negative study. It was designed to show improvement in overall survival in these ideal settings in patients with FIGO stage IIIB and C, they excluded A, these low volume tumors that should absolutely be getting surgery. So FIGO stage IIIB and C and IVA and B that were fit enough to undergo radical surgery randomized to primary cytoreduction or neoadjuvant with interval, and were all given the correct chemo. Dr. Linda Duska: And they were allowed bevacizumab and PARP, also. They could have bevacizumab and PARP. Dr. Kathleen Moore: They were allowed bevacizumab and PARP. Not many of them got PARP, but it was distributed equally, so that would not be a confounder. And so that was important. Overall survival is the endpoint. It was a big study. You know, it was almost 600 patients. So appropriately powered. So let's look at what they reported. When they looked at the patients who were enrolled, this is a large study, almost 600 patients, 345 in the primary cytoreductive arm and 343 in the neoadjuvant arm. Complete resection in these patients was 70% in the primary cytoreductive arm and 85% in the neoadjuvant arm. So in both arms, it was very high. So your selection of site and surgeon worked. You got people to their optimal outcome. So that is very different than any other study that has been reported to date. But what we saw when we looked at overall survival was no statistical difference. The median was, and I know we do not like to talk about medians, but the median in the primary cytoreductive arm was 54 months versus 48 months in the neoadjuvant arm with a hazard ratio of 0.89 and, of course, the confidence interval crossed one. So this is not statistically significant. And that was the primary endpoint. Dr. Linda Duska: I know you are getting to this. They did look at PFS, and that was statistically significant, but to your point about what are we looking for for a reasonable PFS difference? It was about two months difference. When I think about this study, and I know you are coming to this, what I thought was most interesting about this trial, besides the fact that the OS, the primary endpoint was negative, was the subgroup analyses that they did. And, of course, these are hypothesis-generating only. But if you look at, for example, specifically only the stage III group, that group did seem to potentially, again, hypothesis generating, but they did seem to benefit from upfront surgery.  And then one other thing that I want to touch on before we run out of time is, do we think it matters if the patient is BRCA germline positive? Do we think it matters if there is something in particular about that patient from a biomarker standpoint that is different? I am hopeful that more data will be coming out of this study that will help inform this. Of course, unpowered, hypothesis-generating only, but it's just really interesting. What do you think of their subset analysis? Dr. Kathleen Moore: Yeah, I think the subsets are what we are going to be talking about, but we have to emphasize that this was a negative trial as designed. Dr. Linda Duska: Absolutely. Yes. Dr. Kathleen Moore: So we cannot be apologists and be like, "But this or that." It was a negative trial as designed. Now, I am a human and a clinician, and I want what is best for my patients. So I am going to, like, go down the path of subset analyses. So if you look at the stage III tumors that got complete cytoreduction, which was 70% of the cases, your PFS was almost 28 months versus 21.8 months. Dr. Linda Duska: Yes, it becomes more significant. Dr. Kathleen Moore: Yeah, that hazard ratio is 0.69. Again, it is a subset. So even though the P value here is statistically significant, it actually should not have a P value because it is an exploratory analysis. So we have to be very careful. But the hazard ratio is 0.69. So the hypothesis is in this setting, if you're stage III and you go for it and you get someone to no gross residual versus an interval cytoreduction, you could potentially have a 31% reduction in the rate of progression for that patient who got primary cytoreduction. And you see a similar trend in the stage III patients, if you look at overall survival, although the post-progression survival is so long, it's a little bit narrow of a margin.  But I do think there are some nuggets here that, one of our colleagues who is really one of the experts in surgical studies, Dr. Mario Leitao, posted this on X, and I think it really resonated after this because we were all saying, "But what about the subsets?" He is like, "It's a negative study." But at the end of the day, you are going to sit with your patient. The patient should be seen by a GYN oncologist or surgical oncologist with specialty in cytoreduction and a medical oncologist, you know, if that person does not give chemo, and the decision should be made about what to do for that individual patient in that setting. Dr. Linda Duska: Agreed. And along those lines, if you look carefully at their data, the patients who had an upfront cytoreduction had almost twice the risk of having a stoma than the patients who had an interval cytoreduction. And they also had a higher risk of needing to have a bowel resection. The numbers were small, but still, when you look at the surgical complications, as you've already said, they're higher in the upfront group than they are in the interval group. That needs to be taken into account as well when counseling a patient, right? When you have a patient in front of you who says to you, "Dr. Moore, you can take out whatever you want, but whatever you do, don't make me a bag." As long as the patient understands what that means and what they're asking us to do, I think that we need to think about that. Dr. Kathleen Moore: I think that is a great point. And I have definitely seen in our practice, patients who say, "I absolutely would not want an ostomy. It's a nonstarter for me." And we do make different decisions. And you have to just say, "That's the decision we've made," and you kind of move on, and you can't look back and say, "Well, I wish I would have, could have, should have done something else." That is what the patient wants. Ultimately, that patient, her family, autonomous beings, they need to be fully counseled, and you need to counsel that patient as to the site that you are in, her volume of disease, and what you think you can achieve. In my opinion, a patient with stage III cancer who you have the site and the capabilities to get to no gross residual should go to the OR first. That is what I believe. I do not anymore think that for stage IV. I think that this is pretty convincing to me that that is probably a harmful thing. However, I want you to react to this. I think I am going to be a little unpopular in saying this, but for me, one of the biggest take-homes from TRUST was that whether or not, and we can talk about the subsets and the stage III looked better, and I think it did, but both groups did really well. Like, really well. And these were patients with large volume disease. This was not cherry-picked small volume stage IIIs that you could have done an optimal just by doing a hysterectomy. You know, these were patients that needed radical surgery. And both did well. And so what it speaks to me is that anytime you are going to operate on someone with ovary, whether it be frontline, whether it be a primary or interval, you need a high-volume surgeon. That is what I think this means to me. Like, I would want high volume surgeon at a center that could do these surgeries, getting that patient, my family member, me, to no gross residual. That is important. And you and I are both in training centers. I think we ought to take a really strong look at, are we preparing people to do the surgeries that are necessary to get someone to no gross residual 70% and 85% of the time? Dr. Linda Duska: We are going to run out of time, but I want to address that and ask you a provocative question. So, I completely agree with what you said, that surgery is important. But I also think one of the reasons these patients in this study did so well is because all of the incredible new therapies that we have for patients. Because OS is not just about surgery. It is about surgery, but it is also about all of the amazing new therapies we have that you and others have helped us to get through clinical research. And so, how much of that do you think, like, for example, if you look at the PFS and OS rates from CHORUS and EORTC, I get it that they're, that they're not the same. It's different patients, different populations, can't do cross-trial comparisons. But the OS, as you said, in this study was 54 months and 48 months, which is, compared to 2010, we're doing much, much better. It is not just the surgery, it is also all the amazing treatment options we have for these patients, including PARP, including MIRV, including lots of other new therapies. How do you fit that into thinking about all of this? Dr. Kathleen Moore: I do think we are seeing, and we know this just from epidemiologic data that the prevalence of ovarian cancer in many of the countries where the study was done is increasing, despite a decrease in incidence. And why is that? Because people are living longer. Dr. Linda Duska: People are living longer, yeah. Dr. Kathleen Moore: Which is phenomenal. That is what we want. And we do have, I think, better supportive care now. PARP inhibitors in the frontline, which not many of these patients had. Now some of them, this is mainly in Europe, will have gotten them in the first maintenance setting, and I do think that impacts outcome. We do not have that data yet, you know, to kind of see what, I would be really interested to see. We do not do this well because in ovarian cancer, post-progression survival can be so long, we do not do well of tracking what people get when they come off a clinical trial to see how that could impact – you know, how many of them got another surgery? How many of them got a PARP? I think this group probably missed the ADC wave for the most part, because this, mirvetuximab is just very recently available in Europe. Dr. Linda Duska: Unless they were on trial. Dr. Kathleen Moore: Unless they were on trial. But I mean, I think we will have to see. 600 patients, I would bet a lot of them missed the ADC wave. So, I do not know that we can say we know what drove these phenomenal – these are some of the best curves we've seen outside of BRCA. And then coming back to your point about the BRCA population here, that is a really critical question that I do not know that we're ever going to answer. There have been hypotheses around a tumor that is driven by BRCA, if you surgically cytoreduced it, and then chemically cytoreduced it with chemo, and so you're starting PARP with nothing visible and likely still homogeneous clones. Is that the group we cured? And then if you give chemo first before surgery, it allows more rapid development of heterogeneity and more clonal evolution that those are patients who are less likely to be cured, even if they do get cytoreduced to nothing at interval with use of PARP inhibitor in the front line. That is a question that many have brought up as something we would like to understand better. Like, if you are BRCA, should you always just go for it or not? I do not know that we're ever going to really get to that. We are trying to look at some of the other studies and just see if you got neoadjuvant and you had BRCA, was anyone cured? I think that is a question on SOLO1 I would like to know the answer to, and I don't yet, that may help us get to that. But that's sort of something we do think about. You should have a fair number of them in TRUST. It wasn't a stratification factor, as I remember. Dr. Linda Duska: No, it wasn't. They stratified by center, age, and ECOG status Dr. Kathleen Moore: So you would hope with randomization that you would have an equal number in each arm. And they may be able to pull that out and do a very exploratory look. But I would be interested to see just completely hypothesis-generating what this looks like for the patients with BRCA, and I hope that they will present that. I know they're busy at work. They have translational work. They have a lot pending with TRUST. It's an incredibly rich resource that I think is going to teach us a lot, and I am excited to see what they do next. Dr. Linda Duska: So, outside of TRUST, we are out of time. I just want to give you a moment if there were any other messages that you want to share with our listeners before we wrap up. Dr. Kathleen Moore: It's an exciting time to be in GYN oncology. For so long, it was just chemo, and then the PARP inhibitors nudged us along quite a bit. We did move more patients, I believe, to the cure fraction. When we ultimately see OS, I think we'll be able to say that definitively, and that is exciting. But, you know, that is the minority of our patients. And while HRD positive benefits tremendously from PARP, I am not as sure we've moved as many to the cure fraction. Time will tell. But 50% of our patients have these tumors that are less HRD. They have a worse prognosis. I think we can say that and recur more quickly. And so the advent of these antibody-drug conjugates, and we could name 20 of them in development in GYN right now, targeting tumor-associated antigens because we're not really driven by mutations other than BRCA. We do not have a lot of things to come after. We're not lung cancer. We are not breast cancer. But we do have a lot of proteins on the surface of our cancers, and we are finally able to leverage that with some very active regimens. And we're in the early phases, I would say, of really understanding how best to use those, how best to position them, and which one to select for whom in a setting where there is going to be obvious overlap of the targets. So we're going to be really working this problem. It is a good problem. A lot of drugs that work pretty well. How do you individualize for a patient, the patient in front of you with three different markers? How do you optimize it? Where do you put them to really prolong survival? And then we finally have cell surface. We saw at ASCO, CDK2 come into play here for the first time, we've got a cell cycle inhibitor. We've been working on WEE1 and ATR for a long time. CDK2s may hit. Response rates were respectable in a resistant population that was cyclin E overexpressing. We've been working on that biomarker for a long time with a toxicity profile that was surprisingly clean, which I like to see for our patients. So that is a different platform. I think we have got bispecifics on the rise. So there is a pipeline of things behind the ADCs, which is important because we need more than one thing, that makes me feel like in the future, I am probably not going to be using doxil ever for platinum-resistant disease. So, I am going to be excited to retire some of those things. We will say, "Remember when we used to use doxil for platinum-resistant disease?" Dr. Linda Duska: I will be retired by then, but thanks for that thought. Dr. Kathleen Moore: I will remind you. Dr. Linda Duska: You are right. It is such an incredibly exciting time to be taking care of ovarian cancer patients with all the opportunities.  And I want to thank you for sharing your valuable insights with us on this podcast today and for your great work to advance care for patients with GYN cancers. Dr. Kathleen Moore: Likewise. Thanks for having me. Dr. Linda Duska: And thank you to our listeners for your time today. You will find links to the TRUST study and other studies discussed today in the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:   Dr. Linda Duska  @Lduska Dr. Kathleen Moore Follow ASCO on social media:     @ASCO on X (formerly Twitter) ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures of Potential Conflicts of Interest:    Dr. Linda Duska:   Consulting or Advisory Role: Regeneron, Inovio Pharmaceuticals, Merck, Ellipses Pharma  Research Funding (Inst.): GlaxoSmithKline, Millenium, Bristol-Myers Squibb, Aeterna Zentaris, Novartis, Abbvie, Tesaro, Cerulean Pharma, Aduro Biotech, Advaxis, Ludwig Institute for Cancer Research, Leap Therapeutics  Patents, Royalties, Other Intellectual Property: UptToDate, Editor, British Journal of Ob/Gyn  Dr. Kathleen Moore: Leadership: GOG Partners, NRG Ovarian Committee Chair Honoraria: Astellas Medivation, Clearity Foundation, IDEOlogy Health, Medscape, Great Debates and Updates, OncLive/MJH Life Sciences, MD Outlook, Curio Science, Plexus, University of Florida, University of Arkansas for Medical Sciences, Congress Chanel, BIOPHARM, CEA/CCO, Physician Education Resource (PER), Research to Practice, Med Learning Group, Peerview, Peerview, PeerVoice, CME Outfitters, Virtual Incision Consulting/Advisory Role: Genentech/Roche, Immunogen, AstraZeneca, Merck, Eisai, Verastem/Pharmacyclics, AADi, Caris Life Sciences, Iovance Biotherapeutics, Janssen Oncology, Regeneron, zentalis, Daiichi Sankyo Europe GmbH, BioNTech SE, Immunocore, Seagen, Takeda Science Foundation, Zymeworks, Profound Bio, ADC Therapeutics, Third Arc, Loxo/Lilly, Bristol Myers Squibb Foundation, Tango Therapeutics, Abbvie, T Knife, F Hoffman La Roche, Tubulis GmbH, Clovis Oncology, Kivu, Genmab/Seagen, Kivu, Genmab/Seagen, Whitehawk, OnCusp Therapeutics, Natera, BeiGene, Karyopharm Therapeutics, Day One Biopharmaceuticals, Debiopharm Group, Foundation Medicine, Novocure Research Funding (Inst.): Mersana, GSK/Tesaro, Duality Biologics, Mersana, GSK/Tesaro, Duality Biologics, Merck, Regeneron, Verasatem, AstraZeneca, Immunogen, Daiichi Sankyo/Lilly, Immunocore, Torl Biotherapeutics, Allarity Therapeutics, IDEAYA Biosciences, Zymeworks, Schrodinger Other Relationship (Inst.): GOG Partners